hg_79892.1

Basic information about the TSS

---

TSS ID: hg_79892.1 Species: human Chr: chr7		Start: 99558770 End: 99558810 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000422164.5 ENST00000422647.5 ENST00000427931.5 Distance: 0 GeneID: 79027 HGNC/MGI_ID: HGNC:30899 UniProt_ID: C9IYG2 C9JS03 C9JUB9

Gene_name: zinc finger protein 655 Gene_symbol: ZNF655 Gene_synonyms: VIK VIK-1 Gene_source: HGNC:30899

TATA-Box annotation

---

Distance to TSS:	-35
Nearest PromoterID:	NM_001085368
Entrez ID:	79027
Nearest Unigene:	Hs.599798
Nearest Refseq:	NM_024061
Nearest Ensembl:	ENSG00000197343
Gene Name:	zinc finger protein 655
Gene Alias:	VIK|VIK-1
Gene Description:	zinc finger protein 655
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.701493
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZNF655 p2@ZNF655 p3@ZNF655 p4@ZNF655 p5@ZNF655 p6@ZNF655 p7@ZNF655
Sample		p1@ZNF655	p2@ZNF655	p3@ZNF655	p4@ZNF655	p5@ZNF655	p6@ZNF655	p7@ZNF655
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.66	4.48	1.56	8.38	0.78	0.39	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	27.92	4.25	0.81	7.69	0.81	0.61	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.97	5.59	2.12	9.26	0.77	0.77	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	18.92	5.82	1.66	6.65	0.62	0.62	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	25.65	6.52	0.67	8.55	1.35	0.90	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	24.03	5.62	1.36	7.36	2.33	0.58	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.16	5.45	2.18	8.93	2.40	0.44	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	28.82	5.09	0.73	7.75	0.97	0.73	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.57	4.27	2.14	9.62	1.07	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	53.33	6.38	1.16	21.45	0.58	2.32	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	47.70	8.08	2.43	16.17	1.62	0.81	4.45
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	50.41	7.32	3.25	16.67	2.03	0.00	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.66	6.13	2.10	2.90	0.64	1.13	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	17.74	4.21	1.35	1.20	0.90	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	4.61	1.32	1.32	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.59	3.52	1.51	1.01	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.07	4.37	1.31	0.66	0.66	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.98	4.64	2.11	0.84	0.84	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	4.80	0.53	2.13	0.00	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.20	3.31	2.11	1.20	1.65	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	23.26	5.61	1.60	1.47	1.74	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.54	4.32	1.73	2.93	0.86	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.75	4.14	2.20	1.68	1.55	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.84	4.85	0.97	2.18	0.49	1.70	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.16	4.90	1.55	2.06	1.03	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.89	5.38	0.32	3.80	1.90	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.88	3.85	1.10	2.20	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.05	6.13	0.94	1.41	0.94	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.64	3.88	1.29	1.62	1.62	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	5.61	1.45	2.35	1.27	1.63	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.89	6.28	1.05	0.21	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.77	4.69	2.15	1.17	0.98	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.27	4.43	2.11	1.90	0.63	1.27	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	21.94	3.63	0.99	1.65	1.98	0.99	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.82	3.18	1.31	1.87	0.75	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.85	6.52	2.11	1.53	1.53	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.21	4.09	2.45	1.84	2.04	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.39	4.63	2.22	2.42	1.81	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.77	5.40	0.81	1.89	1.08	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.69	4.80	2.40	1.68	1.20	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.82	6.35	1.41	0.94	0.71	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.32	4.68	1.17	1.02	1.02	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.72	7.59	1.48	0.63	0.84	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.63	6.12	3.15	1.22	1.75	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	24.09	4.62	1.61	2.21	2.01	1.41	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.24	5.12	4.42	1.63	1.86	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.23	5.52	1.92	2.64	1.20	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.48	5.66	2.09	2.68	1.79	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.43	6.94	2.87	2.15	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.65	7.08	0.61	0.61	1.42	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.93	6.56	1.23	1.02	2.66	1.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.68	6.67	1.78	2.45	0.89	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	27.98	0.00	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.81	7.10	1.77	1.42	1.06	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.21	5.30	1.66	1.66	1.99	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	25.17	5.03	3.36	2.52	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	15.61	4.13	0.46	1.38	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.21	6.48	1.94	1.30	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.63	5.78	1.28	0.00	0.64	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.77	5.97	1.89	1.57	0.94	2.51	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	20.45	3.53	3.53	1.41	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.63	3.36	3.36	0.56	1.12	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.90	3.98	0.80	0.80	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	3.06	1.36	1.02	0.34	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.52	5.20	1.62	0.97	0.97	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.52	2.84	0.35	0.35	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	7.90	7.90	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.11	2.93	0.98	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.86	1.49	1.49	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	0.00	0.94	0.47	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.24	1.32	0.33	0.99	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	20.11	0.31	0.00	1.86	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	20.48	1.22	2.14	0.61	0.31	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	7.92	3.64	0.79	1.27	2.06	0.95	0.32
Adipocyte - breast, donor2	11327-117E4	8.66	4.01	2.89	1.28	2.41	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	12.09	3.94	1.91	0.64	1.91	0.64	0.13
Adipocyte - omental, donor2	11474-119C7	8.22	2.24	1.49	1.49	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	7.70	2.68	2.01	2.01	1.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	10.21	3.19	1.28	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	6.32	2.26	2.26	0.90	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.52	3.30	2.61	1.22	1.04	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.82	8.61	3.13	2.15	1.56	1.56	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	12.10	3.35	2.32	0.77	0.77	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	9.76	6.69	1.12	0.84	2.51	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	16.46	4.70	2.35	1.18	1.76	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.50	6.68	2.73	1.93	2.82	1.45	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	13.88	2.90	2.90	0.97	1.94	2.26	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	2.13	2.67	1.07	1.60	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	2.78	2.23	0.56	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.98	5.82	1.66	0.83	3.74	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	11.80	4.77	2.26	1.26	2.76	2.01	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	9.16	4.25	2.62	1.31	0.65	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	10.05	2.44	2.13	0.91	2.13	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	14.59	2.43	2.43	1.77	1.33	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	21.87	2.87	1.79	2.15	1.79	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.89	1.98	1.80	0.90	2.70	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	0.00	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.40	2.67	1.23	1.23	0.82	1.03	0.00
Anulus Pulposus Cell, donor1	11248-116E6	17.62	5.03	2.06	1.60	1.49	0.69	0.11
Anulus Pulposus Cell, donor2	11463-119B5	17.39	4.16	2.20	1.22	2.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	3.15	1.35	1.35	1.80	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.47	1.74	4.78	1.30	1.74	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	2.14	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.86	3.59	1.49	0.90	2.39	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	5.06	3.79	1.26	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	0.66	1.32	0.00	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	3.90	1.62	0.32	1.95	1.30	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	1.94	2.43	0.97	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	1.19	4.16	0.00	1.78	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.78	1.51	1.13	0.38	2.64	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	2.18	2.18	0.00	2.18	2.90	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	1.25	0.00	3.76	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.57	2.80	2.14	0.99	1.81	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	0.00	4.09	0.00	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.22	3.77	1.21	0.15	1.51	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.57	4.29	3.21	2.14	2.14	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.31	2.27	1.70	0.94	0.94	1.13	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.82	2.41	0.53	0.53	1.34	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	2.93	0.98	0.98	2.93	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.63	2.16	2.82	1.33	1.16	0.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	1.20	0.00	0.00	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.46	2.74	2.06	0.34	1.37	1.20	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	3.88	0.97	0.49	3.88	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	1.90	2.66	0.76	1.52	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	1.21	0.00	0.00	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	4.56	3.42	0.00	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.12	1.71	2.14	0.64	0.64	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.71	3.10	1.55	0.52	1.03	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.10	3.28	1.88	0.47	1.88	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.47	1.93	1.29	0.32	1.61	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	2.14	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	4.09	2.92	1.17	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.92	1.81	1.51	0.30	2.71	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	2.38	2.38	2.38	3.56	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	1.53	1.02	0.00	2.03	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.90	2.29	2.80	1.27	3.57	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	1.91	0.64	0.64	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	2.16	2.16	1.73	2.16	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.99	1.69	2.12	1.27	1.69	0.85	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	1.16	1.74	0.58	1.45	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	3.78	1.89	0.94	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.97	1.86	2.37	1.02	2.54	1.19	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	4.23	6.34	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.50	1.29	1.29	0.64	0.86	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	1.80	1.20	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	6.56	1.46	0.00	2.92	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	2.76	2.30	0.46	1.38	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.36	1.78	1.02	1.27	1.27	1.27	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.50	1.45	3.30	1.03	2.06	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	3.67	0.31	1.22	1.53	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.04	1.91	3.35	1.43	2.39	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.53	1.77	1.77	1.55	3.55	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	4.58	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	1.11	2.77	1.11	1.66	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.47	1.59	2.12	1.32	1.06	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.91	2.91	1.09	0.36	1.45	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.11	3.07	1.84	1.84	0.86	0.49	0.25
Astrocyte - cerebellum, donor2	11580-120F5	12.15	6.68	2.57	1.20	0.68	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	13.00	0.84	0.42	0.84	0.21	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	31.02	1.39	0.35	5.23	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	41.58	5.99	1.29	5.34	0.00	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	39.38	1.64	0.75	5.37	0.15	0.75	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	28.10	5.28	6.31	2.87	5.85	2.98	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.19	4.26	6.51	2.63	4.51	3.88	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.56	4.10	6.03	2.62	5.35	1.59	0.00
Basophils, donor1	12241-129G9	26.15	12.29	4.18	1.05	1.83	5.23	1.31
Basophils, donor2	12242-129H1	46.18	18.40	5.05	5.05	3.25	6.13	1.08
Basophils, donor3	12243-129H2	22.20	12.79	5.73	3.38	5.59	6.91	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	4.74	4.10	1.29	0.22	2.16	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	11.43	2.74	3.66	0.91	1.37	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	14.35
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	2.51	1.26	2.51	1.88	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	13.31	5.82	2.70	1.46	2.91	1.25	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	12.44	7.37	3.68	1.61	2.76	2.76	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	9.18	3.06	1.62	1.26	2.16	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.39	2.78	5.05	5.98	1.34	0.72	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	47.28	2.33	6.75	6.06	3.03	1.63	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.35	7.67	0.96	2.56	3.20	2.88	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	38.32	14.09	6.20	2.82	7.33	6.20	0.56
CD14+ Monocytes, donor2	11305-117B9	43.24	12.25	7.61	3.16	8.17	6.87	1.11
CD14+ Monocytes, donor3	11381-118B4	45.66	15.15	5.49	2.85	6.15	5.93	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	21.79	16.98	6.79	1.13	9.62	8.77	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.54	15.54	5.69	3.03	7.96	6.07	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	18.41	16.44	6.25	2.30	6.25	6.25	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	36.57	30.07	7.81	3.18	13.44	17.78	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	27.16	30.48	6.03	2.72	5.43	8.45	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	32.22	25.35	8.53	3.79	10.90	10.90	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.29	20.76	7.03	4.52	8.70	10.71	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	25.12	18.49	4.14	1.93	6.35	7.73	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	32.48	23.55	7.19	2.48	8.43	8.93	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	28.00	19.78	4.50	3.13	7.83	16.45	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	25.82	18.87	6.05	2.31	7.66	11.93	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	34.82	33.73	5.66	3.48	9.36	14.36	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	32.08	10.54	3.98	3.75	7.49	10.77	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	27.46	15.84	3.70	1.58	4.75	7.92	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	14.42	7.77	3.33	5.55	11.09	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	32.28	27.37	7.59	3.27	10.56	12.35	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	22.75	18.96	5.19	3.79	4.79	8.58	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	25.40	27.69	4.37	2.71	5.20	15.82	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	32.72	18.53	7.32	4.35	11.44	12.35	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.72	18.55	3.39	3.62	6.11	10.63	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	24.01	17.46	5.24	1.75	3.93	9.17	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	23.94	19.37	7.80	2.96	7.53	15.33	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.74	28.26	6.98	2.79	10.29	12.04	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.87	26.51	7.57	7.15	10.52	18.94	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	35.27	22.96	6.43	2.94	10.66	13.78	2.94
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	29.94	14.80	7.05	2.47	7.05	10.22	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	33.34	22.37	4.83	3.51	10.53	13.16	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.60	18.66	4.88	1.92	8.37	11.68	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	28.99	16.35	4.09	4.46	2.23	8.55	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	36.00	26.51	5.17	4.10	8.62	11.42	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	34.81	17.20	4.09	3.69	7.37	10.65	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	22.02	18.54	3.48	2.78	6.26	5.79	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	30.39	23.66	3.25	3.48	5.80	12.53	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	27.90	13.30	7.19	2.62	5.01	5.89	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	28.64	12.70	6.01	1.85	8.32	6.47	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	22.74	11.70	4.98	0.65	4.77	7.80	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	30.37	20.24	9.81	2.49	14.01	12.61	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	18.51	16.07	7.86	2.97	12.75	10.48	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	20.51	19.40	6.47	3.34	9.59	10.26	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	37.26	17.61	6.38	1.79	6.63	8.93	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	28.76	12.52	9.00	1.98	7.03	6.37	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	30.32	13.05	6.53	1.89	5.47	5.26	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	6.10	10.16	2.03	4.06	8.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.71	21.02	15.59	6.78	6.78	9.49	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	59.03	13.46	16.57	1.04	8.28	12.43	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	42.64	15.46	13.86	2.67	9.59	10.13	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	41.81	15.01	24.12	2.14	12.33	9.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	51.24	22.46	17.55	4.21	7.72	7.02	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	14.12	14.90	1.57	11.77	10.98	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	60.64	26.37	27.68	2.64	2.64	7.91	0.00
CD19+ B Cells, donor1	11544-120B5	76.44	17.26	22.19	4.93	8.22	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	71.82	15.96	12.33	2.18	7.25	7.25	0.00
CD19+ B Cells, donor3	11705-123B4	79.26	11.61	14.64	6.56	4.54	4.54	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.89	6.46	2.02	5.25	5.25	4.44	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.59	3.99	2.40	5.19	2.00	2.40	3.20
CD34+ Progenitors, donor1	11545-120B6	20.08	6.02	1.00	5.02	3.01	7.03	0.00
CD34+ Progenitors, donor2	11625-122B5	44.38	11.24	4.49	5.06	1.69	5.62	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	14.28	12.02	3.76	2.63	5.26	3.76	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	14.21	7.89	3.83	2.71	3.61	5.86	1.58
CD4+ T Cells, donor1	11225-116C1	105.69	19.64	13.93	7.50	8.21	6.78	0.36
CD4+ T Cells, donor2	11306-117C1	74.71	16.53	20.21	3.67	12.25	6.12	0.61
CD4+ T Cells, donor3	11382-118B5	59.78	17.99	9.45	4.57	5.79	6.10	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.47	20.16	15.06	5.87	13.53	11.49	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	45.59	17.97	14.37	4.94	10.56	10.56	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	42.54	24.43	13.22	4.89	10.64	14.66	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	123.74	16.59	9.96	5.69	4.74	3.32	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	96.22	18.96	21.07	7.73	9.83	8.43	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	108.78	16.48	19.78	9.89	9.89	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	33.82	22.11	11.71	4.77	11.56	11.56	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	28.64	24.06	12.03	3.22	11.69	10.85	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.76	15.96	10.96	4.67	14.19	8.38	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	69.93	22.86	10.76	7.62	12.10	8.97	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	72.32	24.11	16.07	5.94	12.93	11.18	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	72.60	23.32	15.84	6.60	6.60	7.48	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	30.36	22.77	13.07	5.90	17.29	9.70	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.06	14.34	7.27	3.53	13.92	9.56	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.05	15.37	8.69	4.01	8.02	8.35	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	84.84	15.50	20.94	7.34	15.23	6.80	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	107.19	25.19	23.58	5.90	17.69	9.65	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	96.83	21.52	21.52	3.59	19.73	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	40.24	24.48	13.35	5.56	15.76	12.42	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	33.58	20.15	10.18	4.33	11.05	10.18	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	38.88	19.96	13.66	5.46	10.72	11.14	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	50.05	22.25	21.24	8.09	8.09	4.55	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	62.39	24.26	14.73	5.20	12.13	8.67	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	68.42	20.48	15.69	5.67	9.59	9.15	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	84.13	19.30	18.81	4.95	7.92	6.43	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	83.09	19.39	13.85	7.39	10.16	10.16	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	92.12	15.35	22.33	2.79	9.77	11.17	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	97.76	25.75	22.71	6.65	11.35	10.80	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	98.16	29.45	20.12	6.87	16.69	10.80	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	101.64	23.10	16.94	10.78	7.70	13.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	66.61	26.86	18.26	7.88	10.74	8.24	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	96.95	33.24	13.85	2.77	5.54	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	101.49	20.63	8.84	9.17	4.26	4.58	0.33
CD8+ T Cells, donor2	11307-117C2	102.87	19.52	6.01	7.51	3.00	6.01	0.00
CD8+ T Cells, donor3	11383-118B6	135.84	20.96	11.11	11.87	6.56	4.54	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	14.68	5.51	2.52	2.06	1.84	2.06	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.14	5.75	3.35	2.40	1.20	2.64	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.76	4.65	2.74	1.37	2.74	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.01	6.30	3.90	3.30	1.50	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.36	5.76	3.36	2.64	0.72	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.05	5.23	2.27	2.05	1.14	1.82	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.78	5.87	2.82	2.17	1.09	1.52	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	20.00	4.47	0.79	1.05	1.05	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.00	5.63	2.58	1.88	0.94	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	22.94	7.25	1.81	3.02	0.30	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.63	2.61	0.58	2.61	0.87	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.85	5.86	2.66	4.00	0.53	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.51	8.32	0.88	3.50	1.31	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	21.41	8.20	1.37	4.10	0.46	2.73	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	8.20	2.98	2.98	1.49	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.89	5.76	1.80	1.44	0.36	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.31	6.33	2.01	2.88	1.44	2.30	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.56	4.48	2.59	1.89	1.65	1.41	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.11	7.61	2.85	3.49	1.27	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.92	7.38	2.46	2.46	0.92	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.16	7.69	0.32	3.53	0.64	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.57	8.03	1.53	3.06	1.15	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.16	5.52	0.79	1.97	1.58	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	22.69	5.29	2.27	3.03	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	52.19	8.03	4.01	8.03	0.80	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	29.38	13.99	4.90	9.09	1.40	4.90	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	13.02	6.01	7.01	3.01	4.01	1.00
Cardiac Myocyte, donor1	11525-119I4	10.97	3.66	5.48	1.83	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	7.91	1.48	2.96	0.99	0.00	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	7.16	1.26	2.21	0.74	0.53	0.74	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.40	5.55	0.69	0.35	5.89	1.73	1.04
Chondrocyte - de diff, donor2	11338-117F6	6.04	2.84	1.42	1.42	1.78	1.42	1.07
Chondrocyte - de diff, donor3	11410-118E6	8.65	4.32	1.82	0.57	3.19	1.48	0.68
Chondrocyte - re diff, donor2	11339-117F7	8.06	6.27	1.79	1.79	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	2.43	1.62	1.21	1.21	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	35.92	6.89	1.95	2.30	1.84	0.11	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	23.94	6.20	1.07	1.28	1.50	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.82	5.40	2.74	2.57	0.53	0.18	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.68	4.77	4.40	2.20	1.93	1.01	0.28
Corneal Epithelial Cells, donor1	11526-119I5	9.22	6.37	1.10	1.32	0.88	0.66	0.66
Corneal Epithelial Cells, donor2	11606-120I4	6.83	4.55	0.00	3.41	3.41	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.95	4.09	2.56	1.53	2.81	2.30	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.24	13.37	2.81	0.66	5.61	7.59	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.30	10.09	1.89	0.95	6.94	11.67	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	10.35	0.00	0.00	10.35	13.80	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.61	9.72	2.81	0.86	4.10	5.94	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	96.00	10.59	5.12	6.49	1.37	4.10	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	92.05	3.26	3.92	5.88	2.61	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	90.01	7.74	8.23	9.19	1.45	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	1.67	2.33	0.00	1.83	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	2.35	0.59	0.00	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	1.70	1.13	0.28	0.85	1.13	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	1.57	0.00	0.39	0.39	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	1.45	1.75	0.58	1.16	0.00	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	2.59	1.18	0.71	0.71	0.47	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	2.98	1.05	0.70	1.58	1.40	0.53	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	0.89	0.66	0.00	1.11	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	3.65	0.30	0.00	0.30	0.00	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	0.56	0.28	0.00	0.28	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	0.00	0.59	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	0.00	0.00	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	0.28	0.43	0.14	0.28	0.00	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	1.60	1.60	0.80	0.40	0.40	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	1.57	0.00	0.00	0.00	0.00	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	3.73	2.24	0.75	1.62	0.62	0.50	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	2.61	1.74	1.09	0.65	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	3.30	2.69	0.37	2.56	0.37	0.37	0.61
Endothelial Cells - Vein, donor1	11267-116G7	3.41	3.41	0.00	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	0.00	2.10	0.00	1.40	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	2.83	1.73	0.00	0.63	0.47	0.00	0.63
Eosinophils, donor1	12244-129H3	30.49	30.49	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	54.46	108.92	3.30	1.65	13.20	33.01	0.00
Eosinophils, donor3	12246-129H5	21.40	74.90	14.27	7.13	7.13	32.10	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	3.91	2.44	0.98	1.22	1.47	0.73	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	4.16	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.14	9.03	1.64	0.41	0.82	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.15	2.19	1.31	0.99	2.08	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.78	1.63	2.06	0.87	1.84	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.31	5.34	2.55	1.82	2.55	0.73	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	14.74	8.05	4.78	1.91	6.55	4.78	3.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.75	3.27	1.90	0.95	4.01	0.95	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.65	6.59	4.48	2.90	3.69	1.84	3.43
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.94	4.32	5.65	1.66	5.32	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	11.79	3.63	0.00	0.91	0.91	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	11.37	0.76	1.52	2.27	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.25	3.31	1.10	1.10	2.05	0.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	12.43	4.55	3.33	2.12	2.12	1.52	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.06	2.79	2.28	1.90	2.54	1.27	0.63
Fibroblast - Cardiac, donor6	11460-119B2	12.43	1.97	4.09	0.76	2.73	0.91	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.52	2.55	1.61	0.80	1.07	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	16.39	3.02	0.43	1.29	1.73	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	0.00	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	50.05	8.30	3.00	7.38	1.38	1.61	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	16.79	6.61	3.56	1.19	3.39	1.19	0.17
Fibroblast - Dermal, donor1	11269-116G9	8.92	3.29	1.88	1.64	2.11	1.41	0.23
Fibroblast - Dermal, donor2	11346-117G5	12.26	1.89	1.42	1.89	3.30	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	12.69	6.77	2.18	1.57	2.18	1.69	0.00
Fibroblast - Dermal, donor4	11450-119A1	24.76	2.94	2.94	1.92	1.36	0.57	0.11
Fibroblast - Dermal, donor5	11454-119A5	36.11	4.01	2.09	5.23	1.92	0.52	0.35
Fibroblast - Dermal, donor6	11458-119A9	31.19	2.27	3.09	4.55	3.57	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	16.45	5.41	4.37	1.87	3.33	2.08	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	21.75	12.58	3.93	2.88	5.50	2.36	1.57
Fibroblast - Gingival, donor2	11318-117D4	24.78	2.77	2.90	1.98	2.11	0.92	0.53
Fibroblast - Gingival, donor3	11394-118C8	22.14	5.70	3.67	1.55	3.38	1.16	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	14.54	4.16	2.08	3.12	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.50	2.47	2.47	2.29	2.29	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	28.22	7.02	2.34	2.81	5.61	1.87	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.53	9.06	2.16	2.30	3.79	2.43	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.41	6.00	4.23	3.18	2.12	1.76	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.01	7.75	3.22	1.46	2.49	1.61	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.45	7.64	2.18	2.05	2.18	1.64	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.77	6.69	3.51	3.73	2.85	1.21	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.89	11.15	3.52	2.20	3.67	1.32	0.15
Fibroblast - Lung, donor1	11270-116H1	5.44	2.72	2.72	0.00	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	22.38	7.46	2.98	5.97	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	14.77	2.32	1.69	1.06	1.27	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	7.50	5.00	1.67	2.50	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	0.00	1.40	0.00	4.20	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	3.36	0.84	1.68	0.28	1.40	0.56
Fibroblast - Mammary, donor1	11540-120B1	15.83	5.28	5.28	1.62	4.06	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	0.00	3.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.02	4.46	1.94	2.91	0.97	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.31	4.25	2.88	1.67	1.21	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	27.84	6.43	3.67	1.53	3.06	1.53	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.41	7.25	3.43	1.53	1.14	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.03	4.86	2.43	1.89	2.97	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.35	7.54	2.09	1.51	2.32	1.74	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.71	1.99	1.66	1.11	1.44	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.05	4.47	2.64	2.24	1.02	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	2.00	0.67	1.34	0.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.12	2.77	1.98	0.79	1.58	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	31.95	11.91	3.97	2.78	2.78	2.18	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.99	7.99	2.31	1.07	2.31	1.07	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	10.25	5.91	1.97	1.18	3.94	1.77	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.95	13.84	2.41	4.21	3.91	2.41	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.98	8.31	2.37	1.84	5.40	2.70	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.03	12.40	4.05	2.78	4.81	2.78	6.33
Fibroblast - skin normal, donor1	11553-120C5	10.01	7.38	2.30	1.15	2.30	2.63	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.85	11.43	3.61	3.21	5.01	4.01	2.01
Fibroblast - skin normal, donor2	11561-120D4	13.36	5.53	3.42	1.00	2.81	1.51	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	21.16	13.90	5.74	1.51	5.44	4.23	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	14.66	10.27	3.81	1.41	3.56	1.82	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.82	11.62	3.76	1.54	5.64	2.22	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	21.68	11.50	3.94	2.63	4.27	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.83	5.43	2.88	1.70	2.45	2.34	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	16.87	3.88	1.52	1.86	3.04	0.67	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.53	6.74	2.20	1.73	2.67	1.73	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	66.48	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	18.30	14.82	2.61	4.36	3.49	8.72	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.28	10.92	2.08	2.25	3.29	1.91	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.97	7.55	2.60	2.86	5.20	2.08	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.56	7.92	2.56	2.56	3.32	2.56	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.90	0.77	0.77	2.30	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	24.88	2.55	0.64	3.83	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.53	2.00	1.14	3.99	0.00	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.09	1.38	0.00	6.07	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.76	1.14	0.46	3.65	0.68	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.97	0.59	0.79	2.18	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.17	2.38	1.32	3.97	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	40.77	0.98	0.98	4.57	0.98	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	24.76	1.33	0.44	2.21	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	29.40	1.55	0.42	4.24	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	28.08	2.34	0.62	4.31	0.12	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	26.06	2.42	0.00	5.10	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.73	1.12	0.25	4.21	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.27	1.80	0.55	7.06	0.00	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	29.89	1.83	0.20	4.88	0.61	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.19	1.37	0.46	6.39	0.46	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.78	3.24	0.87	3.24	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	28.20	1.53	1.31	1.97	0.44	0.87	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	25.71	1.18	0.00	3.55	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.82	1.43	0.95	3.81	0.32	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.55	2.01	0.67	3.35	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.76	1.01	0.81	2.82	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	25.45	1.53	1.02	3.39	0.51	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.41	2.39	0.98	3.81	0.98	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.07	1.25	0.73	4.58	0.62	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.23	1.37	0.34	4.78	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.78	0.66	0.22	3.87	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.88	1.33	0.75	4.33	0.42	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.83	0.61	0.20	6.33	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.69	0.83	0.41	3.51	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.67	0.58	0.46	2.88	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.18	2.17	1.00	4.34	0.17	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.08	1.54	0.00	3.53	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.74	1.11	0.37	2.46	0.12	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.23	0.97	0.32	3.40	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	22.13	0.64	0.64	4.81	0.64	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.24	1.42	0.76	2.75	0.19	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.09	0.32	0.47	3.32	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	26.15	0.30	0.30	2.74	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.53	1.57	0.73	4.08	0.42	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.13	0.44	1.32	1.76	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.11	1.12	0.84	1.40	0.84	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.50	2.04	1.11	2.78	1.02	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.44	2.41	1.07	1.87	1.07	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	19.28	0.61	1.22	2.60	0.77	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.03	1.17	0.52	2.20	0.91	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	19.79	0.27	1.08	2.71	1.36	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.80	1.84	1.47	1.66	0.74	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	20.83	0.66	0.66	1.97	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	20.83	1.98	1.98	2.98	0.99	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.28	1.45	1.19	2.24	0.40	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.15	2.02	1.61	1.61	0.81	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	33.80	2.80	3.30	2.29	0.51	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	40.41	1.59	0.60	7.56	0.00	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	31.28	2.00	0.46	3.85	0.15	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	39.28	2.05	1.23	5.32	0.00	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	14.39	3.13	0.00	2.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.28	2.26	0.28	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	29.98	2.31	0.46	4.15	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	32.17	9.90	0.00	9.90	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.43	2.32	0.39	4.64	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	0.00	0.00	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	3.48	1.74	3.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	25.39	2.93	0.98	4.23	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	27.18	1.24	0.41	3.29	1.65	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	3.33	0.00	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	27.41	0.56	0.28	5.59	0.00	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	24.19	1.31	0.00	2.94	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	0.84	3.36	4.19	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	27.99	1.27	0.00	6.04	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.40	1.36	0.68	3.74	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	0.00	0.00	12.53	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.77	1.15	0.57	5.73	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.10	0.89	0.00	2.96	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	35.58	1.69	0.00	6.78	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	25.68	0.83	1.24	3.31	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	21.86	1.84	1.38	4.37	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	0.00	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.45	0.77	0.77	5.77	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	1.96	0.33	2.61	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	25.42	2.68	1.34	2.01	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	30.44	0.00	1.16	6.93	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	40.74	1.37	0.68	8.56	0.00	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.37	1.42	0.47	2.83	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	23.54	0.00	0.00	3.62	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.56	1.02	0.00	4.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.12	1.20	0.80	4.79	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.57	2.47	0.49	5.92	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	42.50	0.00	0.00	9.44	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.34	0.00	0.00	4.08	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.87	0.44	0.44	3.51	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	36.45	3.39	1.70	7.63	0.00	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	1.19	0.60	3.58	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	1.46	0.00	4.37	0.97	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	5.71	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	6.24	1.66	1.25	1.66	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	7.87	4.50	1.12	4.50	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.51	5.39	2.85	0.95	2.85	1.27	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.92	2.92	2.09	0.42	1.67	0.84	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.52	4.53	1.39	0.93	2.67	1.04	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.95	4.05	1.86	1.86	3.04	1.01	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.51	4.32	2.50	1.14	0.91	1.37	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.49	4.15	1.53	2.19	2.84	1.09	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.80	3.87	1.07	1.72	3.01	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7.32	4.09	1.72	0.86	1.72	1.94	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.59	3.61	1.49	1.99	1.62	1.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.15	3.09	1.03	0.86	2.06	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	5.77	2.24	0.64	0.96	0.64	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	0.00	0.56	0.00	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.66	1.30	0.87	0.87	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.41	3.17	0.35	1.06	1.41	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	0.73	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.22	1.57	0.87	1.05	0.87	0.87	0.17
Hepatocyte, donor1	11523-119I2	10.90	6.05	3.63	1.21	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	19.39	4.31	0.00	4.31	6.46	2.15	0.00
Hepatocyte, donor3	11684-122I1	10.43	9.82	4.29	0.61	5.52	8.59	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.81	2.61	3.92	5.87	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.76	3.15	1.75	1.40	0.52	0.52	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.55	4.80	2.06	0.96	0.96	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	0.00	0.00	0.00	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68	0.00	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	4.15	0.00	4.15	0.00	1.38	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	5.01	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	0.00	2.56	2.56	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	4.57	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	32.49	3.25	4.87	11.37	1.62	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	3.33	1.67	5.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	3.63	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	22.50	2.65	1.32	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	29.93	2.22	1.11	4.43	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	0.00	0.00	5.24	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	24.56	5.67	0.63	4.41	1.89	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	35.57	3.09	3.09	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	3.88	7.75	3.88	0.65	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	3.22	3.22	1.61	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	33.41	7.33	4.89	2.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	25.19	4.20	2.52	3.36	0.42	1.26	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	31.34	5.63	4.02	7.23	1.61	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	2.77	3.69	2.77	1.85	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	15.08	0.00	15.08	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	26.43	1.42	1.42	3.78	1.42	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	22.67	1.81	0.91	2.72	3.63	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	30.13	8.61	3.23	1.08	1.08	2.15	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	40.65	6.35	2.54	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	32.86	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	28.06	5.74	3.83	4.46	1.91	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	1.82	3.65	7.29	3.65	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	5.71	3.57	1.43	1.43	1.43	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	3.32	9.95	0.00	0.00	3.32	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.00	3.70	2.47	2.78	0.00	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	1.76	0.00	5.27	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	6.29	3.14	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	30.60	1.39	2.09	2.09	0.70	2.78	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	8.85	2.21	8.85	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	6.48	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	44.47	1.74	6.98	5.23	0.87	2.62	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	18.00	0.00	0.00	9.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	83.63	3.48	3.48	3.48	0.00	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	44.80	7.47	5.33	5.33	2.13	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	41.56	2.77	2.77	1.39	2.77	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	5.70	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	37.74	2.76	4.60	2.76	2.76	1.84	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	0.00	6.05	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	12.42	24.83	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	4.23	6.34	4.23	0.00	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.24	2.86	1.22	1.14	1.96	0.82	0.41
Keratinocyte - epidermal, donor2	11349-117G8	7.61	1.17	1.76	2.34	0.59	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	27.45	3.69	3.12	3.03	1.42	1.04	0.28
Keratinocyte - oral, donor1	11251-116E9	19.30	5.56	4.20	1.70	3.18	1.70	0.11
Keratocytes, donor1	11527-119I6	29.57	3.78	1.72	4.47	1.03	0.69	0.34
Keratocytes, donor2	11607-120I5	23.44	5.86	3.52	2.34	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	14.42	1.78	1.58	2.17	0.99	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	2.20	4.40	4.40	2.20	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	2.16	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.45	3.11	1.85	2.42	0.35	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	7.87	4.04	2.42	1.01	1.51	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	1.07	0.36	0.12	0.47	0.24	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	0.00	0.28	0.00	0.00	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	0.63	0.47	0.00	0.31	0.00	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	0.00	0.00	0.54	0.54	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	0.00	0.95	0.00	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	0.11	0.86	0.00	0.32	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	1.64	0.82	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	0.51	0.25	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	0.42	0.84	0.00	0.70	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	0.00	1.19	0.40	0.79	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	0.00	0.39	0.19	0.58	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.11	0.56	0.19	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	0.35	0.35	0.70	0.00	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	0.95	0.48	0.24	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	0.69	0.14	0.14	0.27	0.14	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1.54	0.62	0.00	0.92	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	0.00	0.62	0.00	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	0.73	0.37	0.37	0.73	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	0.33	0.00	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	0.29	0.29	0.29	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	0.00	0.50	0.00	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	0.27	0.00	0.00	0.54	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	0.45	0.15	0.00	0.30	0.15	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	0.52	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1.05	0.21	0.00	0.42	0.00	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	0.15	1.05	0.30	0.60	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.06	0.00	0.00	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	0.56	0.19	0.00	0.38	0.38	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	0.64	0.85	0.11	0.74	0.11	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	0.48	1.94	0.00	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	0.66	0.33	0.33	0.66	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	0.37	0.25	0.12	0.50	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	0.74	1.85	0.00	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	0.25	0.00	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	0.41	0.55	0.00	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	0.00	1.61	0.32	1.29	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	0.91	0.61	0.00	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	0.56	0.42	0.00	0.28	0.14	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1.42	0.36	0.00	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	0.78	0.31	0.00	0.62	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	0.36	0.00	1.07	1.07	0.72	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	0.65	0.33	0.00	0.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.24	0.24	0.00	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	0.50	0.74	0.00	0.50	0.12	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.02	0.00	0.00	0.77	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1.19	0.60	0.00	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.00	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.04	8.66	2.96	1.37	4.79	5.70	0.00
Macrophage - monocyte derived, donor2	11313-117C8	8.26	8.62	1.84	0.37	5.14	4.95	0.00
Macrophage - monocyte derived, donor3	11389-118C3	10.88	7.47	3.01	0.92	5.11	5.37	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	5.84	3.19	5.84	4.78	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	14.89	7.76	4.75	2.22	1.90	1.11	0.48
Mallassez-derived cells, donor3	11930-125I4	18.21	5.28	3.06	2.08	1.39	1.67	0.14
Mammary Epithelial Cell, donor1	11273-116H4	13.05	4.78	3.99	2.19	4.88	2.99	1.20
Mammary Epithelial Cell, donor2	11350-117G9	16.21	6.66	2.03	4.34	6.08	1.45	0.58
Mammary Epithelial Cell, donor3	11422-118F9	7.48	2.99	2.24	2.00	2.74	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	52.88	18.30	3.39	4.07	0.68	6.78	1.36
Mast cell, donor1	11563-120D6	15.57	8.33	2.81	2.60	2.49	5.08	0.65
Mast cell, donor2	11565-120D8	16.64	6.54	2.97	2.67	3.86	5.05	1.19
Mast cell, donor3	11566-120D9	16.43	6.08	1.80	3.83	3.83	2.70	2.48
Mast cell, donor4	11567-120E1	13.65	5.32	4.25	3.01	3.90	4.08	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	20.40	3.44	3.99	1.89	3.66	5.32	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	7.00	1.75	1.17	2.92	4.67	0.58
Mast cell, expanded, donor5	11939-126A4	16.75	4.59	2.64	3.56	2.18	3.90	0.80
Mast cell, expanded, donor8	11941-126A6	15.40	11.55	2.85	2.51	3.01	6.36	1.51
Melanocyte - dark, donor1	11502-119F8	0.90	2.19	0.00	0.90	0.30	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	10.38	1.38	2.08	1.38	4.50	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	14.92	1.16	2.25	1.96	0.51	0.43	0.00
Melanocyte - light, donor1	11274-116H5	4.23	2.35	1.88	0.47	0.47	0.71	0.00
Melanocyte - light, donor2	11351-117H1	6.14	0.68	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	1.73	0.87	0.87	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	14.89	1.87	1.56	1.04	1.46	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	15.06	2.42	1.08	1.61	0.81	1.61	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	25.71	2.68	1.34	2.95	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	22.33	4.47	1.74	2.48	1.49	0.12	0.12
Meningeal Cells, donor2	11573-120E7	18.93	4.84	0.88	2.64	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	24.37	7.58	2.12	3.67	0.82	0.24	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.53	4.28	1.71	3.14	1.14	1.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.47	6.34	2.01	1.21	3.02	2.21	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	2.63	0.00	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	2.62	1.31	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	2.87	1.44	0.72	4.31	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.32	5.08	1.91	1.27	1.69	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	6.53	1.51	1.51	2.51	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.78	2.20	2.20	2.86	1.54	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.92	3.65	0.73	0.73	2.92	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.03	4.50	3.48	1.64	2.25	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.53	2.91	2.35	0.83	2.35	1.11	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.04	1.49	1.12	0.37	0.74	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.37	3.16	1.32	1.05	1.32	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.61	0.89	0.30	0.89	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.33	1.92	0.64	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	17.01	4.25	3.90	1.42	2.48	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.45	3.75	1.56	0.63	0.94	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	0.73	1.45	2.90	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	10.34	6.10	2.12	1.06	3.18	2.12	0.53
Mesothelial Cells, donor2	12156-128G5	5.51	3.50	2.00	0.50	1.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	11.49	4.19	2.02	1.45	2.60	1.23	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	8.10	2.70	1.35	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.87	9.60	3.20	0.74	3.94	4.43	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.07	9.13	5.89	1.18	5.30	6.48	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.54	8.68	2.79	0.93	5.89	3.10	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.09	6.64	2.90	0.41	2.70	4.36	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	4.63	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	10.51	3.75	0.75	6.51	6.01	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.71	10.71	1.40	0.93	4.65	4.65	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.96	9.75	2.85	1.02	5.49	4.06	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	9.50	3.96	0.40	2.77	3.56	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	6.19	0.88	1.77	4.42	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.36	8.74	2.66	1.14	1.52	3.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	2.63	3.95	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.64	4.67	2.76	0.42	2.33	1.27	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	3.68	1.84	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.17	2.98	1.19	1.19	2.09	1.79	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	1.68	0.00	0.00	1.68	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.78	6.52	1.25	0.75	3.01	2.26	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	8.08	3.33	0.71	2.61	3.57	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.74	3.32	2.21	0.55	0.55	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.83	6.22	3.22	0.69	2.76	2.07	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.47	9.68	2.31	0.42	1.89	2.52	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.76	7.75	2.24	1.43	2.45	3.47	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.94	3.86	3.00	0.86	3.22	2.15	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.56	7.11	2.45	0.44	1.56	1.56	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.54	5.91	1.75	0.66	2.19	2.41	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	6.08	2.03	2.03	2.03	3.04	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	4.97	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.24	3.81	2.72	0.54	0.54	1.63	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	7.94	2.35	0.59	3.23	3.82	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	5.45	2.18	1.09	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.90	5.29	1.92	0.00	1.92	3.84	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.00	10.41	2.40	1.20	1.60	8.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	9.60	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	5.01	2.00	0.50	3.00	3.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.07	5.69	1.75	2.19	2.63	6.13	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	3.31	2.21	2.21	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	3.20	3.84	1.28	0.64	4.48	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	17.35	8.93	3.22	2.73	2.73	3.22	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	6.96	4.18	2.09	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	8.84	2.21	4.42	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.02	9.23	2.05	1.37	3.42	3.08	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.57	7.00	1.75	0.88	3.06	2.19	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.07	4.26	1.42	1.07	0.36	2.49	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.67	7.01	5.61	0.84	2.81	3.65	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	7.07	2.91	1.66	1.25	2.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	17.48	6.41	2.33	1.17	0.58	4.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	17.50	8.75	3.32	2.41	2.11	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	23.37	12.94	3.76	0.42	2.09	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	4.62	3.69	0.92	0.92	4.62	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	5.69	6.26	1.71	2.85	3.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.82	7.19	2.49	0.97	0.55	2.07	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.44	7.26	1.81	3.37	1.04	2.07	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.30	8.58	2.14	1.29	2.14	2.57	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	5.08	0.64	0.00	0.64	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.15	4.00	2.67	1.87	1.87	2.40	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	11.08	3.89	1.80	2.99	5.39	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.66	6.64	1.70	1.55	1.27	2.12	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.43	8.92	0.96	2.87	3.19	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	25.65	10.17	2.43	1.55	1.99	2.65	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	19.34	3.79	3.03	0.76	0.38	2.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.75	5.97	3.98	4.26	2.27	1.70	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	23.11	11.80	3.69	3.20	2.95	1.72	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	3.26	1.96	0.65	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.99	4.12	2.94	5.00	1.76	2.35	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	28.26	14.13	4.32	1.44	2.02	4.32	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.02	10.72	2.06	3.30	3.71	2.89	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.59	8.93	3.28	2.38	2.38	2.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	7.53	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	7.13	5.35	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.11	11.17	2.63	1.64	3.61	1.97	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	5.26	4.21	1.05	7.36	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.71	9.29	4.35	0.59	3.36	2.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	15.83	2.79	0.00	6.52	7.45	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.51	7.89	4.51	1.50	3.00	2.25	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.26	8.79	3.20	1.33	2.40	2.66	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.76	8.26	2.49	0.57	3.17	2.26	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	6.63	1.47	0.00	3.68	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.76	8.06	3.66	1.10	2.93	2.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	9.33	1.56	1.56	1.56	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.29	5.88	3.21	0.00	1.60	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	15.46	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	7.07	0.00	1.01	6.06	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	6.75	2.95	0.00	2.53	3.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	1.36	4.09	0.00	8.17	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.81	1.91	1.27	1.27	3.81	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	11.34	3.24	0.81	0.81	4.86	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	4.53	7.55	0.00	7.55	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	5.71	0.00	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	9.79	0.00	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00	12.55	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	16.37	8.40	1.51	2.37	1.08	1.51	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.36	7.32	1.05	2.09	4.18	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	0.67	2.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	5.43	0.83	0.00	2.09	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.69	4.75	2.09	0.95	0.76	1.14	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	3.19	3.19	0.00	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	2.72	0.00	0.00	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	9.19	0.00	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	6.28	1.67	0.00	0.42	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.48	7.44	1.86	1.16	1.39	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	3.51	0.81	0.54	1.08	1.62	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.56	4.41	2.31	1.26	1.26	1.05	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	22.27	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	4.96	1.99	0.99	1.99	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.66	4.06	1.89	0.27	1.08	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.93	4.76	2.72	0.00	2.95	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.49	3.76	1.63	0.49	1.80	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.93	5.65	2.19	0.55	1.46	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	5.83	3.18	0.53	4.24	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	6.60	2.40	1.80	3.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.22	4.27	1.31	0.66	0.66	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.72	4.88	3.25	0.49	3.09	0.81	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.17	4.23	2.29	0.18	1.41	0.53	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	4.92	2.81	0.00	1.41	0.00	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	9.19	1.84	0.46	0.92	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	5.46	2.25	0.00	4.50	1.29	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	9.66	5.17	1.03	0.34	0.69	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	5.06	7.59	2.53	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.91	4.46	2.45	1.11	1.78	0.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.35	4.66	2.96	0.00	5.08	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.07	5.93	1.90	0.24	1.19	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	8.16	2.58	0.43	1.72	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	18.06	9.03	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.00	6.00	1.33	0.33	1.67	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	4.06	2.25	0.00	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	2.38	2.38	0.79	1.98	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	4.64	0.93	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.70	6.81	2.65	1.14	2.27	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.41	5.54	1.63	0.33	1.63	1.96	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	2.18	2.61	0.00	1.31	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.57	5.43	2.26	0.00	1.81	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	6.17	4.41	0.00	3.53	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	8.64	3.32	0.00	2.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.91	3.97	2.48	0.00	2.98	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.19	3.06	3.06	0.00	4.59	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.49	9.98	2.72	0.30	1.81	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.95	4.86	1.55	1.33	2.65	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.26	2.71	4.07	0.00	2.03	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	20.44	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	7.32	6.10	0.00	1.83	3.05	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.92	2.20	3.15	0.00	2.20	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.26	5.15	2.72	0.30	2.12	1.21	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	2.37	0.79	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	6.80	2.27	0.00	3.40	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.70	6.96	1.86	0.87	3.48	1.49	0.25
Myoblast, donor2	11322-117D8	9.59	7.48	3.45	0.77	4.03	1.53	0.58
Myoblast, donor3	11398-118D3	10.76	5.21	2.19	1.18	2.69	1.85	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	134.55	25.68	28.75	12.99	11.24	7.73	0.15
Natural Killer Cells, donor1	11230-116C6	83.64	18.76	8.00	7.07	5.23	4.61	0.00
Natural Killer Cells, donor2	11311-117C6	90.17	19.30	10.55	5.43	4.22	5.73	0.30
Natural Killer Cells, donor3	11387-118C1	88.16	23.19	8.47	7.18	5.52	7.36	0.55
Neural stem cells, donor1	11275-116H6	34.48	3.27	0.73	6.90	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	57.77	1.93	1.93	13.48	0.00	0.00	0.00
Neurons, donor1	11494-119E9	36.41	3.41	0.00	15.93	0.00	1.14	0.00
Neurons, donor2	11574-120E8	32.36	2.20	0.66	2.64	0.00	0.66	0.00
Neurons, donor3	11655-122E8	37.00	1.64	0.00	4.93	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	11.14	39.90	7.42	6.50	7.42	11.14	2.78
Neutrophils, donor2	11314-117C9	17.39	28.99	2.90	2.90	5.80	17.39	2.90
Neutrophils, donor3	11390-118C4	34.82	57.42	11.61	6.72	18.94	25.04	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	21.85	6.06	1.54	0.71	2.37	0.83	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	2.93	0.98	0.98	0.65	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.64	1.60	1.80	0.80	2.01	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.08	5.37	2.34	0.83	0.96	1.24	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.62	3.47	3.18	2.03	2.03	1.30	0.29
Olfactory epithelial cells, donor3	11935-125I9	10.10	9.87	2.72	0.68	2.04	1.70	0.23
Olfactory epithelial cells, donor4	11936-126A1	17.43	5.75	1.46	1.36	1.46	0.49	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	12.04	1.20	0.60	1.81	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.04	3.19	1.70	1.06	1.70	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	4.57	0.00	1.14	1.14	3.43	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	3.10	0.62	0.00	2.48	1.86	0.62
Osteoblast, donor1	11277-116H8	6.64	3.71	4.89	0.78	1.37	0.59	0.00
Osteoblast, donor2	11354-117H4	13.34	3.51	3.51	2.11	2.81	1.40	0.00
Osteoblast, donor3	11426-118G4	18.31	4.62	3.55	1.60	3.38	1.42	0.53
Pancreatic stromal cells, donor1	11249-116E7	12.55	6.40	2.95	2.02	4.46	1.35	0.93
Pericytes, donor1	11491-119E6	12.13	2.89	0.89	1.00	0.33	0.11	0.00
Pericytes, donor2	11571-120E5	12.45	2.49	1.13	1.13	0.68	0.23	0.00
Pericytes, donor3	11652-122E5	10.99	2.24	2.03	1.63	1.02	0.81	0.00
Perineurial Cells, donor1	11499-119F5	23.73	5.99	1.02	1.92	0.79	0.00	0.11
Perineurial Cells, donor2	11579-120F4	10.40	3.59	3.68	1.66	2.39	0.83	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.98	10.52	13.71	2.55	11.16	7.97	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	44.08	12.98	5.88	3.67	6.86	5.14	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	58.37	15.14	10.22	6.08	5.44	6.21	0.52
Placental Epithelial Cells, donor1	11278-116H9	5.26	3.59	0.96	2.63	2.39	1.67	0.48
Placental Epithelial Cells, donor2	11355-117H5	12.20	1.11	1.11	2.22	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.37	1.37	0.79	0.20	1.96	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	3.16	1.27	1.58	1.90	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	6.00	3.56	1.50	0.75	2.25	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.92	7.31	1.83	1.96	1.83	2.09	0.39
Preadipocyte - breast, donor2	11328-117E5	11.26	4.50	2.48	0.90	2.03	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	11.08	5.86	1.49	0.64	2.77	1.07	0.21
Preadipocyte - omental, donor2	11329-117E6	11.78	6.11	1.31	1.31	0.44	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	8.59	3.44	2.15	1.00	1.86	1.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	13.78	3.94	4.92	0.98	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	7.37	6.45	0.92	1.23	2.76	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	23.20	6.73	4.60	3.19	3.90	1.06	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	19.75	7.32	3.07	2.55	4.09	1.36	0.17
Preadipocyte - visceral, donor1	11280-116I2	18.26	6.52	3.35	1.40	3.35	1.40	0.28
Preadipocyte - visceral, donor2	11357-117H7	20.71	3.68	2.76	2.30	1.84	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	17.35	5.54	3.03	2.40	2.40	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.24	0.75	0.91	1.21	0.45	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	3.79	3.52	1.35	1.22	1.90	1.22	0.54
Prostate Epithelial Cells, donor3	11404-118D9	10.10	3.86	2.33	2.14	2.63	2.27	0.43
Prostate Stromal Cells, donor1	11254-116F3	11.85	3.53	2.73	1.25	2.85	1.48	0.46
Prostate Stromal Cells, donor2	11332-117E9	21.52	7.35	2.87	3.59	2.69	1.26	0.36
Prostate Stromal Cells, donor3	11405-118E1	10.74	5.32	2.50	0.94	2.19	1.25	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	1.82	1.09	1.46	0.36	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.90	0.55	0.83	0.62	0.35	0.42	0.00
Renal Epithelial Cells, donor1	11517-119H5	15.22	1.01	1.01	1.52	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	1.42	0.71	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	15.67	1.16	0.85	1.27	0.21	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.68	0.00	2.04	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1.89	1.89	1.08	0.94	0.81	0.54	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.88	2.00	1.11	2.22	1.11	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.66	1.33	1.33	0.67	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.88	2.86	1.32	1.10	0.22	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	11.91	0.00	0.63	1.25	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.77	1.94	1.11	1.11	0.28	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.13	2.42	0.81	2.42	2.15	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.65	1.69	2.53	0.84	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.67	3.28	2.70	2.12	1.35	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.26	1.30	1.56	0.26	1.04	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.67	1.14	0.57	1.14	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	0.00	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.05	2.01	3.01	1.76	0.50	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	23.39	7.75	3.34	3.61	4.54	2.41	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	39.31	1.79	0.89	3.57	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.32	3.85	1.65	3.30	0.55	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	35.96	4.06	0.00	4.06	0.00	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.14	5.07	2.21	6.63	1.04	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	42.11	5.26	1.39	5.46	0.70	0.99	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	47.96	3.46	1.34	5.69	0.89	1.12	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	53.09	6.82	1.61	6.45	1.12	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	36.48	3.85	0.58	4.08	0.35	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	49.46	4.62	1.85	4.85	0.69	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	40.80	3.83	1.92	4.65	0.96	1.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	39.33	3.18	2.57	4.99	1.21	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.66	5.73	1.61	5.55	0.54	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	39.88	4.02	2.01	7.03	1.00	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.98	3.54	1.18	4.08	0.43	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	41.38	3.10	1.33	8.19	0.44	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	37.66	4.97	2.10	4.40	0.00	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	39.97	4.66	1.58	4.38	0.93	1.02	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	48.10	6.01	1.32	6.76	0.94	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	42.47	4.91	1.33	6.77	0.40	1.59	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	42.25	3.50	1.46	6.52	0.97	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	41.25	3.25	1.34	5.35	1.34	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.04	4.59	1.82	6.83	1.17	1.07	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.57	3.36	1.96	5.33	0.84	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	38.79	5.30	1.88	4.61	1.20	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.38	4.01	1.64	5.65	2.01	1.09	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	36.79	3.31	1.10	5.89	0.61	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	43.65	5.37	1.75	5.64	1.21	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	38.92	2.59	1.65	4.01	0.24	1.18	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.69	2.78	0.99	5.36	0.79	0.99	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	39.05	3.27	2.10	5.61	1.17	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	33.38	6.22	1.87	3.53	0.83	0.83	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	47.56	2.65	1.77	6.86	0.88	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	40.73	5.43	3.55	6.68	0.63	0.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.93	4.44	2.42	5.92	1.62	1.08	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	44.11	3.58	1.53	5.45	0.85	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	38.94	3.66	2.12	5.21	0.19	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.08	3.27	2.58	4.99	1.72	2.24	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	39.78	4.66	1.10	3.98	0.96	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	39.89	6.40	2.63	4.93	1.31	1.15	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	35.96	3.92	1.36	4.94	0.17	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	43.20	5.18	1.04	4.14	1.04	1.04	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	39.18	4.26	1.07	2.67	1.07	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	43.69	1.80	1.24	8.43	0.69	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.48	1.43	0.48	3.81	0.00	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	42.32	2.02	0.60	6.45	0.81	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.03	1.88	0.85	4.61	0.28	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.42	2.79	2.10	2.45	1.40	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.64	3.32	1.81	2.42	0.30	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	32.55	3.67	2.08	3.92	0.86	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	122.99	7.71	3.64	16.16	1.75	2.04	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.85	3.65	2.43	7.30	0.61	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	30.14	2.71	2.41	3.32	1.51	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	40.49	2.71	2.04	4.30	1.13	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	56.91	3.89	0.90	5.39	1.20	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	42.27	3.31	1.77	4.37	0.94	1.42	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.13	3.20	2.77	4.70	0.64	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	55.29	4.81	1.20	6.01	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	20.31	1.69	0.75	1.32	0.56	0.75	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	15.99	2.19	1.31	1.53	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	15.89	2.74	2.74	1.64	3.29	0.00	0.55
Sebocyte, donor2	11301-117B5	10.57	2.30	0.92	0.92	2.30	1.38	0.46
Sebocyte, donor3	11378-118B1	6.60	2.68	1.03	0.21	2.68	0.62	0.00
Sertoli Cells, donor1	11255-116F4	19.88	0.00	3.31	3.31	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	8.47	5.65	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.41	2.20	1.67	1.32	1.58	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	7.23	1.45	2.89	0.00	2.17	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	17.56	0.84	2.51	0.84	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	15.24	2.98	2.83	1.26	1.41	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.80	3.27	3.72	2.53	1.93	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	21.24	4.00	1.69	1.69	1.23	1.23	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	24.45	4.41	2.77	1.13	1.76	1.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	17.98	3.42	3.14	1.28	2.00	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	20.83	2.88	3.87	2.28	1.49	1.39	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.63	2.36	1.43	0.59	1.43	0.76	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	2.17	0.00	1.45	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.60	2.89	2.75	0.55	2.06	0.28	0.14
Skin - palm, donor1	10286-104F7	37.61	5.37	5.37	2.69	5.37	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.35	3.60	2.16	1.73	2.88	0.86	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	45.80	26.99	9.81	11.45	11.45	8.18	21.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.18	4.67	4.02	1.17	2.86	1.30	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	10.43	5.70	0.97	3.20	2.36	1.67	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	14.77	7.17	3.24	2.39	2.81	1.41	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	38.06	28.97	11.21	9.73	14.59	12.26	8.25
Small Airway Epithelial Cells, donor3	11406-118E2	9.89	5.70	1.50	2.40	3.90	2.40	1.05
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.80	2.47	1.54	0.93	1.23	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	17.79	3.78	2.89	1.56	3.11	0.89	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.87	4.70	1.18	3.53	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.75	3.31	1.99	0.66	1.10	1.33	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	3.15	2.36	2.36	3.15	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	9.27	4.64	1.55	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	21.02	3.00	2.00	2.00	4.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.19	2.00	2.13	0.40	1.46	0.53	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.07	6.87	2.88	1.99	1.99	1.55	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.73	2.30	2.05	2.05	2.82	0.77	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.65	6.19	0.65	0.98	0.98	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.95	5.91	1.48	1.18	2.36	1.48	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.10	3.56	2.70	1.42	2.56	0.57	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.97	3.09	2.11	1.79	0.98	0.81	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	13.70	2.13	1.52	1.22	1.22	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.33	3.54	2.53	0.76	2.53	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.44	1.43	1.91	1.43	1.91	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.83	3.54	1.33	1.18	1.77	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.42	1.94	1.72	0.43	1.08	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.07	2.73	1.89	1.05	1.89	1.36	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.90	4.33	1.24	1.70	2.17	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	0.00	2.16	1.08	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.15	2.09	2.69	1.49	1.79	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.02	2.73	1.71	1.02	1.37	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.02	4.40	3.30	1.02	2.04	0.86	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.39	3.72	2.72	0.81	2.11	1.41	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.15	5.69	5.23	1.37	3.41	1.37	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	2.42	0.60	2.42	1.81	1.81	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	22.25	3.71	3.18	1.85	3.18	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.45	5.19	2.40	1.73	2.53	0.93	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.89	4.88	3.38	1.88	4.13	1.25	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.12	3.80	1.52	0.00	1.52	1.27	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.14	4.22	3.92	0.75	3.17	1.21	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	1.50	1.50	0.00	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.63	2.79	2.33	1.40	1.86	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.08	3.53	0.00	2.02	1.51	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.21	2.82	2.51	1.57	3.13	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.01	1.77	0.88	0.59	0.88	1.47	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	21.41	4.67	3.42	2.00	2.25	1.42	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.81	5.14	2.34	1.87	2.34	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.07	3.17	0.72	1.44	1.44	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.06	2.80	3.57	2.04	1.78	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.54	2.82	2.26	1.69	2.07	0.75	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.86	3.07	1.82	0.98	1.12	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.22	2.51	1.93	0.42	1.01	0.50	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.81	2.20	1.22	1.71	0.49	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.04	6.41	2.87	1.10	2.87	2.43	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.85	4.68	1.17	1.17	1.46	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.91	6.03	1.36	0.78	3.69	1.36	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.67	2.91	1.32	0.79	1.06	1.85	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	4.09	1.12	1.12	0.37	1.12	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.62	5.75	3.95	0.36	1.80	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.64	4.83	1.70	0.85	1.70	0.85	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	1.97	1.97	1.18	2.36	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	3.81	2.29	1.02	1.02	0.25	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	3.19	3.99	0.80	0.80	2.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	5.02	3.34	1.67	0.42	1.25	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	9.63	5.50	2.29	1.38	1.83	2.29	0.00
Synoviocyte, donor1	11291-117A4	16.16	4.54	0.34	2.36	2.19	0.50	0.00
Synoviocyte, donor2	11368-117I9	8.05	4.69	3.18	0.84	4.19	2.01	0.67
Synoviocyte, donor3	11440-118H9	11.39	3.57	2.46	0.45	3.35	2.68	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	17.51	3.57	1.79	2.14	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	1.98	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	26.40	5.09	2.78	1.16	1.62	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	11.11	2.65	1.94	1.58	1.43	0.86	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	5.41	2.32	2.71	0.39	1.55	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	15.46	1.72	2.29	0.57	1.72	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	23.74	8.12	4.43	2.34	4.92	3.57	0.86
Urethra, donor2	10319-105A4	28.77	8.99	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.69	3.45	1.59	1.33	1.86	0.53	0.00
Urothelial Cells, donor2	11600-120H7	13.22	2.00	0.40	0.40	1.20	1.60	0.00
Urothelial Cells, donor3	11681-122H7	8.48	1.60	1.38	0.92	1.38	1.15	0.00
Urothelial cells, donor0	11216-116B1	18.50	2.90	1.78	1.11	0.89	1.11	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	34.70	25.80	8.90	6.23	20.47	14.24	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	21.44	11.44	4.29	22.87	20.01	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	22.59	7.53	13.69	3.42	12.32	6.16	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.65	21.00	9.30	4.82	11.02	11.02	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.05	18.01	9.88	1.74	12.20	7.55	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	28.11	17.70	11.45	1.04	20.82	10.41	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	28.45	21.11	11.01	0.92	16.52	12.85	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	23.74	20.08	5.48	2.74	14.61	6.39	0.00
Wilms' tumor cell line:G-401	10809-111A8	23.19	3.21	1.73	2.59	0.74	0.37	0.00
Wilms' tumor cell line:HFWT	10597-108E3	39.60	4.40	4.40	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.73	2.51	3.91	1.12	2.23	0.84	0.00
achilles tendon, donor2	10292-104G4	10.33	6.20	2.07	4.13	2.07	8.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	47.93	2.80	1.78	10.20	0.76	1.02	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	25.54	1.39	7.66	2.32	4.88	0.46	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	84.40	3.56	2.97	11.04	1.54	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	30.20	4.08	7.89	5.17	5.17	1.63	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	27.27	4.50	7.59	6.18	3.09	2.25	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	16.07	20.30	3.38	2.54	4.23	4.02	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	5.44	5.17	1.63	1.91	2.45	2.99	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	20.71	3.53	6.61	5.29	4.41	2.64	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	16.33	6.94	4.90	3.68	2.86	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.82	15.53	17.09	2.33	7.38	3.11	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	9.75	3.31	2.76	1.47	3.31	1.84	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	0.00	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	6.51	3.02	2.09	0.93	2.32	1.16	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.57	4.14	6.21	1.04	5.18	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	8.48	5.55	3.80	0.00	6.14	3.21	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	15.34	7.90	6.51	1.86	4.65	9.30	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	15.22	7.40	4.11	6.17	15.63	9.05	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.76	4.30	1.84	0.00	2.76	1.84	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.12	2.56	2.56	1.28	3.84	0.85	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	6.67	6.37	3.03	1.52	7.28	5.46	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	6.26	6.26	3.13	0.72	4.33	4.33	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	6.46	4.23	4.45	2.45	4.23	4.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.68	4.00	4.00	1.33	2.33	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	46.46	3.72	0.00	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	4.14	3.39	0.75	0.38	1.13	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	16.14	6.98	3.93	3.05	3.49	2.18	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	7.50	0.00	3.75	5.62	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	18.60	2.83	3.30	1.65	2.12	0.94	0.00
adipose tissue, adult, pool1	10010-101C1	19.23	4.03	2.48	1.86	2.33	1.71	0.93
adipose, donor1	10184-103D4	36.94	0.59	0.00	7.04	0.59	0.00	0.00
adipose, donor2	10185-103D5	35.28	1.62	0.41	3.65	0.00	0.00	0.00
adipose, donor3	10186-103D6	24.51	1.09	1.09	3.54	0.27	0.00	0.00
adipose, donor4	10187-103D7	15.60	0.87	0.00	0.87	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	36.93	7.73	8.05	1.10	3.79	2.53	0.16
adrenal gland, adult, pool1	10081-102A9	36.38	3.64	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.62	3.47	5.87	1.87	3.87	0.67	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	72.89	27.87	6.07	6.79	2.14	2.86	0.71
amniotic membrane cells, donor1	12235-129G3	15.30	8.58	2.09	1.85	5.10	2.32	0.93
amniotic membrane cells, donor2	12236-129G4	13.86	8.79	2.37	2.37	4.73	3.04	0.00
amniotic membrane cells, donor3	12237-129G5	11.49	6.48	4.12	2.65	5.30	4.42	1.77
amygdala - adult, donor10196	10167-103B5	36.76	5.93	3.56	2.37	0.00	3.56	1.19
amygdala, adult, donor10252	10151-102I7	46.84	6.49	4.87	3.85	1.42	1.82	1.01
amygdala, newborn, donor10223	10360-105E9	15.17	3.87	1.61	1.29	0.65	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	14.01	4.20	2.29	1.40	2.04	0.51	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.89	20.30	5.96	4.63	3.75	1.99	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	74.16	1.67	0.67	7.68	0.00	0.33	0.00
aorta, adult, pool1	10052-101G7	21.38	3.14	1.96	2.94	1.96	1.18	0.39
appendix, adult	10189-103D9	49.29	9.31	12.03	4.66	8.54	4.27	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	34.05	6.53	7.22	4.13	7.57	3.44	0.69
artery, adult	10190-103E1	13.59	0.00	4.08	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	123.43	12.02	1.16	19.70	0.29	2.17	0.14
b cell line:RPMI1788	10427-106D4	27.66	4.31	7.14	4.01	3.27	1.04	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.58	9.16	1.66	2.22	2.22	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.43	8.34	3.47	2.58	4.37	2.58	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	13.56	3.68	2.01	1.84	2.18	2.85	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.36	8.39	4.47	2.80	4.47	6.15	0.00
bladder, adult, pool1	10011-101C2	36.61	4.78	1.63	2.06	1.41	1.41	0.33
blood, adult, pool1	10053-101G8	17.72	11.07	6.64	2.21	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	5.99	4.28	1.71	2.57	0.00	0.86
bone marrow, adult	10192-103E3	25.64	4.05	5.40	2.70	0.67	2.70	0.00
brain, adult, donor1	10084-102B3	34.85	4.10	2.05	1.03	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	34.19	4.57	2.78	2.90	0.67	1.34	0.11
brain, fetal, pool1	10085-102B4	21.37	0.00	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	12.36	3.37	3.37	2.37	3.25	1.37	0.12
breast, adult, donor1	10080-102A8	18.31	3.79	1.89	0.63	1.26	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.76	12.58	5.46	6.10	5.08	4.83	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.57	3.71	3.71	3.40	4.02	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.99	9.67	6.68	4.37	7.60	5.53	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	66.29	0.94	2.35	8.46	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	51.96	2.52	3.17	4.59	1.42	1.42	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	26.94	0.95	0.95	2.54	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.24	3.46	2.93	4.79	1.33	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	27.63	10.36	3.45	4.61	1.15	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	43.00	6.36	3.18	2.68	1.84	1.67	0.33
caudate nucleus, adult, donor10258	10379-105H1	48.14	6.11	4.58	0.76	3.06	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	17.95	4.39	1.46	1.83	1.10	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	72.83	11.65	0.00	8.74	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	121.70	13.24	2.99	15.16	0.64	1.07	0.64
cerebellum, adult, pool1	10083-102B2	56.23	9.31	2.07	3.10	0.34	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	85.52	16.61	3.32	4.98	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	42.61	7.06	1.76	2.52	0.50	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	24.85	1.46	0.00	0.73	0.73	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	17.11	8.48	3.59	2.59	4.17	2.59	0.29
cervical cancer cell line:ME-180	10553-107I4	11.43	12.59	3.15	2.65	5.47	3.81	1.16
cervix, adult, pool1	10013-101C4	34.12	9.76	3.88	3.67	2.62	1.57	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.22	4.18	3.20	0.98	3.90	0.98	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	37.88	0.00	1.31	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	25.35	1.74	2.98	3.98	1.24	0.50	0.00
choriocarcinoma cell line:SCH	10785-110H2	47.44	2.46	4.07	5.05	1.85	1.23	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	27.04	1.66	4.51	2.85	1.42	0.95	0.00
chorionic membrane cells, donor1	12238-129G6	23.65	6.27	2.28	3.42	1.99	2.56	0.85
chorionic membrane cells, donor2	12239-129G7	30.62	10.04	2.09	5.27	2.09	1.69	0.10
chorionic membrane cells, donor3	12240-129G8	37.36	7.69	8.24	3.30	2.20	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	1.01	1.01	9.09	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.41	5.38	5.38	3.27	4.99	1.73	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	4.86	7.39	4.22	1.27	1.90	3.38	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	35.95	2.82	3.85	3.34	0.77	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	41.36	3.63	5.56	3.63	1.21	1.21	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	46.22	4.07	4.07	3.66	1.83	0.81	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	25.62	2.06	2.94	1.77	2.06	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.29	7.82	3.91	3.39	3.91	2.87	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.94	5.03	2.97	2.74	3.43	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	13.19	3.12	1.04	1.74	3.30	1.21	0.69
colon carcinoma cell line:CACO-2	10513-107D9	13.18	2.01	0.55	4.03	1.28	1.28	0.00
colon carcinoma cell line:COLO-320	10420-106C6	0.38	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	26.18	7.14	4.76	2.38	3.57	2.38	1.19
colon, adult, pool1	10014-101C5	33.37	9.87	4.58	4.23	5.41	5.52	0.35
colon, fetal, donor1	10070-101I7	22.87	6.18	3.09	1.85	2.47	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	41.25	4.58	22.92	13.75	4.58	18.33
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	51.42	16.15	6.37	6.80	4.67	4.67	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.07	8.30	3.32	3.32	2.26	1.36	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	23.83	9.59	3.95	2.40	1.55	2.12	0.00
corpus callosum, adult, pool1	10042-101F6	63.57	5.09	3.76	4.53	1.22	0.77	0.11
cruciate ligament, donor2	10295-104G7	18.64	4.86	4.05	1.62	4.86	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	17.66	4.82	1.61	5.62	0.00	0.80	0.00
diencephalon, adult	10193-103E4	36.00	3.60	2.40	3.12	1.20	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	57.63	3.21	2.07	7.35	0.69	1.38	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.28	8.21	5.64	4.62	3.59	3.33	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.26	6.02	2.89	1.93	1.69	1.93	0.00
ductus deferens, adult	10196-103E7	37.38	6.98	4.98	1.00	2.49	2.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	30.24	7.20	4.32	2.88	4.32	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	40.46	5.15	5.89	3.68	4.41	4.41	0.00
dura mater, adult, donor1	10041-101F5	45.26	9.91	4.62	2.73	2.15	1.65	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	57.96	11.10	1.78	32.42	2.00	1.33	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.20	3.87	2.29	5.02	1.72	0.86	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	16.03	1.85	3.70	0.62	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	20.58	3.63	4.24	0.30	3.03	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.99	5.56	3.09	0.93	2.16	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	18.39	10.51	7.88	0.00	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	46.59	8.72	3.02	4.02	1.34	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.26	11.78	5.26	3.08	7.61	2.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.39	6.11	1.45	1.77	1.77	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	21.23	6.56	2.78	3.33	3.78	1.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	21.67	7.15	4.95	3.52	7.59	3.30	0.88
epididymis, adult	10197-103E8	41.02	5.86	4.60	2.30	1.88	1.47	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	31.40	11.00	5.32	1.42	4.44	1.60	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.85	2.75	3.54	1.57	3.15	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.37	4.32	2.36	2.10	4.19	1.18	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.85	5.31	3.25	2.17	5.12	1.77	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.21	3.14	2.24	1.34	3.47	1.01	0.22
esophagus, adult, pool1	10015-101C6	21.45	9.77	2.76	2.97	4.25	2.44	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	42.20	14.28	3.88	2.13	2.50	2.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	38.63	4.83	4.83	12.07	0.00	9.66	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	6.31	4.21	2.10	2.10	4.21	0.00
eye - muscle medial, donor2	10299-104H2	19.35	8.93	1.49	2.98	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	27.52	3.44	3.44	2.29	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	29.15	8.74	2.91	1.46	2.91	1.46	1.46
eye, fetal, donor1	10054-101G9	23.64	3.31	1.27	1.78	1.27	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	21.29	4.87	4.23	1.67	3.85	1.03	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	23.03	8.78	4.27	1.66	2.14	1.66	0.00
frontal lobe, adult, pool1	10040-101F4	41.56	8.35	2.81	5.63	1.22	2.63	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.11	0.30	3.60	2.10	4.50	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	35.20	2.56	4.57	1.83	4.94	1.28	0.37
gall bladder, adult	10198-103E9	26.80	5.79	3.86	2.17	1.69	2.90	0.72
gamma delta positive T cells, donor1	11937-126A2	64.42	23.08	16.11	4.29	9.13	6.44	0.00
gamma delta positive T cells, donor2	11938-126A3	72.46	18.67	12.70	8.22	4.86	8.59	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.70	3.38	2.32	3.38	1.69	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.50	6.58	4.64	3.67	2.51	2.32	0.19
gastric cancer cell line:AZ521	10549-107H9	40.50	6.39	4.75	4.75	2.79	0.98	0.00
gastric cancer cell line:GSS	10560-108A2	10.07	0.00	0.00	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.55	1.83	2.74	5.25	0.91	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	6.20	3.44	1.72	2.18	1.84	1.84	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	10.08	3.64	1.54	1.12	1.40	0.56	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.23	6.98	3.74	2.49	5.99	2.24	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.00	7.92	2.11	4.33	2.53	0.74	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.60	9.69	3.65	2.95	1.54	1.40	0.14
glioblastoma cell line:T98G	10485-107A8	45.47	8.28	3.20	5.63	3.42	0.77	0.66
glioma cell line:GI-1	10413-106B8	23.43	6.44	4.39	1.17	4.39	1.46	0.59
globus pallidus - adult, donor10196	10175-103C4	40.82	3.64	0.73	2.92	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	63.71	4.15	2.44	4.39	2.20	2.44	0.00
globus pallidus, adult, donor10258	10367-105F7	60.25	1.37	1.37	9.58	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	22.38	3.73	1.07	1.60	2.13	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	34.26	14.68	12.24	14.68	9.79	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	15.68	0.00	0.00	0.00	0.00	15.68
granulosa cell tumor cell line:KGN	10624-108H3	19.52	4.48	0.32	3.52	0.96	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	24.33	1.38	1.84	2.75	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	23.32	0.91	1.37	7.32	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	23.83	0.64	0.64	3.86	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	14.37	1.44	0.00	4.31	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	11.66	0.69	0.00	6.17	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	29.79	3.31	0.00	9.93	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	15.80	14.37	4.60	3.74	3.74	2.30	0.29
heart - mitral valve, adult	10205-103F7	23.02	5.68	2.69	2.09	2.09	2.39	0.30
heart - pulmonic valve, adult	10206-103F8	27.45	4.71	1.83	2.88	1.83	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	32.47	1.67	2.50	1.67	1.67	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	25.51	3.67	1.84	2.24	2.45	2.04	0.00
heart, adult, diseased, donor1	10051-101G6	17.88	2.98	1.28	2.13	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	17.94	2.07	2.30	1.61	2.07	0.23	0.69
heart, fetal, pool1	10046-101G1	38.30	4.31	2.16	5.75	0.92	1.13	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.04	3.70	0.00	0.93	0.93	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	44.00	1.19	1.19	4.76	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.51	2.32	2.98	5.86	1.10	0.77	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	26.58	4.13	0.97	7.40	0.73	1.09	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	30.82	2.93	2.32	7.88	0.71	1.62	0.00
hepatoma cell line:Li-7	10484-107A7	69.29	6.12	1.89	8.12	1.22	0.56	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	21.91	3.02	7.14	3.22	2.71	1.31	0.00
hippocampus - adult, donor10196	10169-103B7	41.64	8.52	0.95	2.84	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	47.76	7.35	2.65	4.49	0.41	1.02	0.20
hippocampus, adult, donor10258	10374-105G5	25.40	4.48	1.49	4.48	0.50	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	22.21	4.93	2.47	0.70	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	32.96	1.83	0.61	3.05	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	25.13	0.20	0.39	2.55	0.20	0.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.67	0.76	0.51	2.29	0.00	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	27.07	1.69	0.56	5.64	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.44	0.77	0.00	3.87	0.00	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	36.44	1.52	0.76	4.56	0.76	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	40.29	0.58	2.34	6.13	0.29	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	37.92	0.65	2.15	5.17	1.29	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	46.71	1.25	0.42	4.59	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.31	0.95	0.95	5.68	0.47	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.93	0.32	2.09	3.21	0.64	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	29.63	2.69	1.35	4.71	0.67	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.13	0.78	0.31	2.97	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	21.62	1.97	0.00	1.97	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	1.75	0.00	1.75	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.95	2.67	0.19	4.39	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	29.22	2.62	0.44	5.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.98	2.50	0.00	8.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	40.88	1.13	0.38	3.01	0.00	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	39.11	0.91	1.36	1.82	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	37.59	0.63	0.31	3.76	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.64	2.12	0.16	2.78	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	29.03	3.19	0.29	3.77	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	31.09	2.99	0.90	2.09	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	22.54	1.29	0.37	3.69	0.18	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	18.26	1.71	0.29	3.14	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	29.40	2.45	0.82	4.90	0.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.70	1.41	0.70	5.28	0.35	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.81	1.58	0.95	4.43	0.32	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.03	1.21	0.00	4.24	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	2.07	0.00	3.10	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.90	1.99	0.66	3.98	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.45	2.05	0.00	4.87	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	28.63	3.07	2.05	5.37	0.51	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	3.03	0.76	2.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	34.95	2.69	1.68	2.02	1.68	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	22.22	1.21	0.24	5.07	0.00	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.51	0.89	0.00	6.68	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.93	2.93	0.49	5.37	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.64	1.83	0.00	5.20	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	74.82	0.00	0.00	13.01	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	35.74	1.32	0.99	3.64	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.55	0.00	0.55	6.57	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	40.53	1.09	1.09	4.34	0.72	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.89	0.71	0.36	6.05	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	1.19	0.00	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.05	4.06	0.54	4.06	0.14	0.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.44	2.16	0.81	2.16	0.27	0.00	0.00
immature langerhans cells, donor1	11904-125F5	23.97	12.59	4.60	2.66	5.09	6.30	0.73
immature langerhans cells, donor2	11905-125F6	29.31	7.92	4.75	1.58	3.96	5.54	3.17
insula, adult, pool1	10039-101F3	40.98	8.61	1.70	5.87	0.66	1.70	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	9.43	9.10	2.60	0.65	3.90	1.63	0.33
kidney, adult, pool1	10017-101C8	27.94	6.91	3.40	3.30	2.20	2.20	0.30
kidney, fetal, pool1	10045-101F9	25.25	3.96	2.90	2.90	1.91	1.13	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	87.34	17.61	7.39	12.07	2.27	2.56	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.29	2.49	1.80	1.94	1.11	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.70	2.75	2.02	1.83	0.92	0.18	0.00
left atrium, adult, donor1	10079-102A7	14.71	6.54	1.63	1.09	0.00	1.09	0.00
left ventricle, adult, donor1	10078-102A6	13.65	2.02	0.51	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	19.15	3.28	3.01	1.64	1.92	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	5.75	1.08	0.36	0.72	2.51	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	4.89	3.80	3.26	0.54	3.26	0.00	1.09
leiomyoma cell line:15425	10571-108B4	8.98	3.64	2.19	0.97	1.21	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	6.27	0.00	0.00	2.09	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	12.99	10.39	2.24	2.13	2.60	2.24	0.83
liposarcoma cell line:KMLS-1	10782-110G8	16.25	6.25	1.41	0.78	2.03	1.25	0.62
liposarcoma cell line:SW 872	10726-110A6	42.40	4.39	3.78	4.63	1.83	1.10	0.37
liver, adult, pool1	10018-101C9	11.99	7.94	4.70	1.13	5.02	2.27	0.00
liver, fetal, pool1	10086-102B5	6.58	1.88	3.76	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	35.29	3.21	2.48	2.92	0.73	0.87	0.29
locus coeruleus, adult, donor10252	10165-103B3	54.63	4.43	2.40	2.58	0.18	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	33.86	4.23	1.97	4.80	0.85	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	21.03	3.36	2.52	0.42	0.42	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	27.68	7.47	2.63	1.94	1.52	1.94	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	6.89	8.96	2.76	1.38	5.52	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	58.26	2.90	6.72	5.27	4.88	2.24	0.26
lung, adult, pool1	10019-101D1	26.93	6.50	3.54	3.07	2.01	2.01	1.30
lung, fetal, donor1	10068-101I5	46.81	7.42	3.14	6.28	6.85	4.00	3.71
lung, right lower lobe, adult, donor1	10075-102A3	23.83	7.79	5.50	3.67	4.12	2.29	1.37
lymph node, adult, donor1	10077-102A5	22.72	7.10	5.68	2.84	3.79	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	22.79	7.01	5.04	1.53	2.19	1.53	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	144.59	21.73	14.19	24.15	6.19	7.55	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	56.07	7.65	7.65	9.34	3.40	5.10	0.85
mature adipocyte, donor1	12231-129F8	23.53	3.11	0.44	3.55	0.89	0.89	0.44
mature adipocyte, donor2	12232-129F9	28.64	3.53	3.32	2.08	0.83	1.45	1.25
mature adipocyte, donor3	12233-129G1	29.40	2.13	2.37	0.95	2.13	1.66	0.47
mature adipocyte, donor4	12234-129G2	25.27	1.58	2.63	1.84	1.58	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	45.75	6.43	3.10	5.48	1.67	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	28.20	3.38	7.90	4.51	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	42.85	7.36	2.57	4.97	1.10	1.10	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	24.14	7.62	1.59	3.81	0.32	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	22.60	4.26	2.99	1.71	0.43	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	37.80	8.94	0.84	3.88	0.34	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	47.11	7.85	2.12	4.03	1.49	1.91	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	3.85	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	43.06	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	21.18	3.95	0.00	2.51	1.08	2.15	0.72
medulla oblongata - adult, donor10196	10174-103C3	37.64	2.60	1.95	3.24	1.30	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	53.41	6.50	2.17	4.33	1.39	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	41.06	4.08	2.69	4.33	0.65	0.73	0.08
medulla oblongata, newborn, donor10223	10361-105F1	24.30	6.25	2.08	2.43	2.08	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	28.34	1.11	0.44	4.43	0.22	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	46.46	3.55	2.81	3.55	1.71	0.61	0.12
melanoma cell line:COLO 679	10514-107E1	23.00	4.60	2.16	4.17	2.30	2.16	0.29
melanoma cell line:G-361	10465-106H6	52.66	2.17	3.26	3.80	2.17	1.09	0.00
meningioma cell line:HKBMM	10691-109F7	21.17	5.25	3.26	2.35	2.17	1.09	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	64.32	1.76	1.76	18.50	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	63.77	2.07	2.59	16.07	0.00	1.04	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.41	8.13	4.30	1.99	5.37	2.30	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.45	5.82	4.00	0.91	2.36	2.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	4.97	2.48	2.07	4.97	2.90	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.49	5.06	3.23	0.42	3.37	1.55	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.13	5.58	3.66	1.35	3.08	2.12	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	6.25	2.08	1.39	5.55	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.50	5.49	2.06	2.40	4.29	1.54	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.78	3.80	2.76	1.61	3.22	1.50	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.59	3.58	2.92	0.80	2.52	1.06	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.15	3.24	3.11	1.49	3.11	0.81	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.64	5.55	1.56	2.70	2.56	0.85	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.82	2.63	4.61	1.98	2.96	1.65	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.86	3.74	3.04	2.08	2.21	0.97	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	14.66	4.54	2.09	1.40	0.70	1.40	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.64	4.49	2.65	1.02	1.84	1.43	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	2.52	3.24	2.16	1.80	1.44	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.31	2.79	2.07	0.41	1.55	1.34	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.21	3.19	1.37	2.05	3.19	1.14	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.01	5.03	4.20	0.84	5.87	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.79	3.14	1.64	1.20	1.05	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	16.72	3.94	2.63	0.88	2.19	0.70	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.09	6.26	1.84	2.21	1.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.17	3.43	1.14	2.58	1.14	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.00	2.53	0.84	2.11	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.85	4.11	6.39	0.00	3.20	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	7.67	1.53	1.53	3.33	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	4.19	2.36	1.31	3.66	1.83	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.24	3.08	2.16	0.62	2.46	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.12	3.77	1.41	0.47	5.65	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.20	5.08	0.68	2.37	5.75	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.07	7.86	3.14	0.79	8.25	2.36	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	6.49	1.85	2.78	4.17	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.25	7.50	2.88	0.58	2.60	1.44	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.37	5.35	1.56	1.12	2.68	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.17	3.85	3.61	1.20	3.12	1.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.73	4.40	2.20	0.73	5.13	3.67	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.05	2.01	2.01	0.67	3.36	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.83	4.50	0.00	0.41	2.46	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.01	3.01	1.29	0.86	3.87	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	2.73	2.73	0.00	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.77	4.22	1.95	1.62	1.62	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	4.36	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	3.73	2.67	1.07	2.13	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	4.09	3.27	0.82	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.22	4.28	1.17	1.17	2.72	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	8.39	2.10	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	2.98	2.98	2.98	1.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	4.77	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	2.96	2.37	0.59	2.37	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	6.09	1.22	1.22	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	4.43	4.43	0.63	2.53	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.24	4.83	2.76	0.69	2.07	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	12.90	2.15	0.00	4.30	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	13.78	0.00	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.74	2.85	1.22	0.41	2.04	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	9.53	0.79	0.79	2.38	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	2.36	2.36	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.30	4.36	1.25	0.62	0.62	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	0.00	0.00	1.34	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	2.37	2.37	0.00	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	2.57	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	2.75	3.44	2.07	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.88	0.99	1.98	0.99	1.98	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	2.24	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	1.27	0.00	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.66	2.01	2.01	0.40	1.61	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	2.18	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	2.53	1.27	0.00	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	11.53	2.43	1.82	1.21	1.21	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	3.29	0.00	3.29	6.59	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.74	3.57	0.99	0.60	2.38	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	1.95	1.30	0.32	1.30	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	2.04	1.02	0.00	4.07	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	7.74	1.55	2.32	2.32	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	46.07	2.36	3.54	2.36	4.96	2.60	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.42	10.66	3.24	3.24	3.01	1.85	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	8.55	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	27.23	6.68	1.23	2.47	1.03	0.41	0.21
mesothelioma cell line:Mero-25	10850-111F4	17.70	6.13	2.27	2.04	0.68	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	16.38	4.65	2.93	1.96	5.38	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	22.81	12.84	1.99	1.11	4.87	1.77	0.44
mesothelioma cell line:Mero-82	10853-111F7	34.43	6.83	1.58	5.78	2.10	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	19.92	8.34	2.55	2.72	1.53	0.85	0.17
mesothelioma cell line:Mero-84	10855-111F9	18.71	3.79	2.02	2.53	1.77	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	16.77	3.73	2.90	0.83	2.28	1.04	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	6.96	1.66	1.82	1.82	1.82	1.16	0.50
mesothelioma cell line:NCI-H226	10846-111E9	19.91	5.43	3.44	2.71	2.90	0.72	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	17.77	9.57	5.64	1.71	3.07	2.05	0.00
mesothelioma cell line:NCI-H28	10845-111E8	20.61	4.58	4.07	0.76	2.80	1.78	0.76
mesothelioma cell line:No36	10857-111G2	36.53	5.87	1.63	5.22	0.98	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	16.53	4.88	1.08	2.44	2.98	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	13.43	3.07	3.45	0.96	3.65	2.49	0.00
migratory langerhans cells, donor2	11902-125F3	11.85	2.69	3.30	0.85	3.54	3.05	0.24
migratory langerhans cells, donor3	11903-125F4	15.26	7.36	4.67	1.62	2.69	3.59	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.06	4.90	1.31	1.63	0.65	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.67	2.76	0.64	3.39	0.00	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	89.84	13.36	8.98	4.61	7.14	2.07	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.12	7.23	4.38	3.23	3.43	3.81	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	11.46	6.10	7.02	1.66	6.10	3.51	0.37
myeloma cell line:PCM6	10474-106I6	29.25	6.72	12.85	5.53	12.45	5.53	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.55	5.07	0.00	4.57	2.03	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.64	13.34	7.26	4.51	3.14	2.35	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.92	8.02	4.12	3.12	3.45	3.12	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.33	7.72	2.50	3.75	3.31	2.13	1.69
nasal epithelial cells, donor2	12227-129F4	11.59	9.38	2.21	3.31	2.76	3.31	1.66
neuroblastoma cell line:CHP-134	10508-107D4	72.93	1.61	1.15	19.56	0.23	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	50.51	7.48	2.81	8.61	1.12	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	38.38	3.59	1.05	9.91	0.21	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	59.63	2.42	0.37	16.03	0.00	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	35.58	1.90	3.08	4.03	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.24	3.96	1.58	4.12	0.48	0.48	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	38.84	1.61	1.81	2.21	0.40	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	36.24	0.00	0.64	6.36	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	18.37	6.65	3.46	2.13	1.86	1.60	0.00
neutrophil PMN, donor1	12133-128D9	29.75	59.50	14.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	18.94	0.00	9.47	0.00	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	64.60	4.57	6.93	6.26	1.35	1.35	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	49.63	4.00	0.80	8.81	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	19.24	5.77	1.60	2.24	2.89	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	25.49	5.52	2.63	1.05	1.58	2.10	0.26
nucleus accumbens, adult, pool1	10037-101F1	40.50	8.06	4.12	4.03	0.84	1.41	0.09
occipital cortex - adult, donor10196	10172-103C1	41.21	8.24	2.06	10.30	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	69.24	8.86	2.95	6.44	1.07	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	15.29	4.37	1.09	1.46	1.09	1.09	1.82
occipital lobe, adult, donor1	10076-102A4	39.10	6.82	2.10	4.46	1.57	1.57	0.26
occipital lobe, fetal, donor1	10073-102A1	43.77	4.72	2.15	5.58	0.43	0.86	0.00
occipital pole, adult, pool1	10036-101E9	28.46	5.28	1.97	3.00	0.63	0.95	0.08
olfactory region, adult	10195-103E6	34.39	5.54	2.87	3.63	0.57	1.15	0.00
optic nerve, donor1	10277-104E7	80.04	2.00	6.00	2.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	10.48	17.43	3.65	2.96	5.70	3.53	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	63.47	3.71	2.20	5.50	0.82	0.55	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.69	7.62	3.22	3.22	5.93	2.03	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	35.69	18.60	7.05	6.82	7.74	3.70	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	21.75	4.70	2.65	1.76	2.35	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	4.67	1.87	0.93	2.80	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	24.81	2.97	1.91	0.85	0.42	0.64	0.21
ovary, adult, pool1	10020-101D2	26.21	5.33	3.32	2.62	2.01	0.70	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	32.08	6.78	2.93	4.40	2.02	0.73	0.37
pancreas, adult, donor1	10049-101G4	24.46	1.88	3.76	0.94	3.76	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.08	5.59	5.87	2.24	3.63	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	17.04	4.26	3.92	3.41	4.77	0.68	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	328.18	35.10	21.36	19.54	11.76	10.27	0.33
paracentral gyrus, adult, pool1	10035-101E8	39.90	8.42	2.01	4.76	0.55	1.01	0.18
parietal cortex, adult, donor10258	10373-105G4	27.89	6.61	3.67	1.47	0.00	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	47.96	9.40	1.88	4.70	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	46.75	8.27	2.00	4.28	0.29	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	37.89	7.31	2.11	4.05	0.62	1.50	0.09
parietal lobe, fetal, donor1	10072-101I9	62.07	0.00	0.00	7.76	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	20.94	4.86	1.87	1.12	0.75	1.87	1.87
parotid gland, adult	10199-103F1	30.83	4.93	5.55	3.08	6.78	0.62	0.00
penis, adult	10200-103F2	33.30	5.91	2.15	2.15	1.61	2.69	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.94	0.93	5.02	0.37	0.37	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	77.80	12.24	8.74	7.14	5.10	3.50	0.44
pineal gland - adult, donor10196	10179-103C8	39.35	3.87	0.65	4.52	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	75.80	4.15	0.59	7.11	0.59	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	38.88	1.25	1.88	3.76	0.00	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	76.90	11.13	4.05	9.11	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	100.59	17.72	5.73	14.07	1.04	3.13	0.52
pituitary gland, adult, donor10258	10378-105G9	63.84	9.36	0.85	10.21	1.70	2.55	0.00
placenta, adult, pool1	10021-101D3	32.14	5.59	5.81	5.05	4.19	2.15	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	25.43	4.24	4.50	2.52	3.18	1.72	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.45	6.69	2.80	2.80	2.65	1.40	0.31
pons, adult, pool1	10033-101E6	46.39	6.89	2.75	6.11	0.69	0.95	0.26
postcentral gyrus, adult, pool1	10032-101E5	34.87	6.89	2.62	2.79	0.44	0.96	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	23.01	8.37	10.46	14.64	23.01	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	11.02	0.00	5.51	5.51	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	23.47	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	25.35	3.79	4.08	2.48	3.79	1.75	0.15
prostate cancer cell line:PC-3	10439-106E7	0.18	0.00	0.00	0.00	0.00	0.00	0.00
prostate, adult, pool1	10022-101D4	25.58	5.26	4.08	1.81	2.63	1.63	0.63
putamen, adult, donor10196	10176-103C5	57.36	8.03	6.14	3.54	0.00	1.42	0.24
putamen, adult, donor10252	10152-102I8	41.18	13.73	3.92	0.00	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	21.86	3.28	0.00	5.46	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	38.90	5.07	5.07	3.14	2.17	1.45	0.24
putamen, newborn, donor10223	10365-105F5	14.24	3.00	1.50	0.00	0.00	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	22.40	3.20	3.49	1.75	1.75	1.75	0.00
rectum, fetal, donor1	10067-101I4	47.29	11.13	9.74	4.17	5.56	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	28.83	3.18	4.03	2.54	3.82	1.06	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.40	1.24	2.90	0.41	2.07	1.24	0.00
retina, adult, pool1	10030-101E3	38.67	4.57	2.29	4.17	0.80	1.09	0.80
retinoblastoma cell line:Y79	10475-106I7	31.18	1.04	0.52	8.31	0.26	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.79	1.84	1.35	2.34	0.49	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	134.69	6.19	1.69	18.00	1.12	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.80	2.27	3.03	0.76	4.55	0.76	0.00
salivary acinar cells, donor1	11771-123I7	12.79	10.84	3.72	1.94	4.53	3.24	2.91
salivary acinar cells, donor2	11772-123I8	12.39	13.91	2.34	1.93	6.33	3.86	2.20
salivary acinar cells, donor3	11773-123I9	13.90	20.52	3.31	3.31	7.94	2.65	1.99
salivary gland, adult, pool1	10093-102C3	37.18	9.72	4.00	2.86	3.43	5.15	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	41.99	10.54	6.24	3.04	3.46	2.36	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	38.20	10.93	7.88	2.47	4.47	2.00	0.24
seminal vesicle, adult	10201-103F3	41.27	5.29	4.76	2.65	2.12	2.12	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	13.12	3.64	0.49	1.70	1.46	2.43	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.30	2.52	1.76	0.00	1.26	0.25	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	2.01	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.83	2.55	3.49	4.43	2.01	0.94	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	4.90	2.06	0.65	0.65	1.16	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	24.83	3.55	1.42	2.13	2.13	2.84	0.00
skeletal muscle, adult, pool1	10023-101D5	13.07	3.96	2.40	1.20	1.92	1.56	0.24
skeletal muscle, fetal, donor1	10066-101I3	11.06	1.01	3.02	1.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	35.98	5.05	3.16	5.05	5.68	1.26	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	29.02	2.00	1.33	5.34	0.67	1.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	54.53	3.78	3.15	5.04	0.32	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	65.73	5.20	9.83	4.05	0.96	0.96	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	34.28	6.59	2.80	10.38	1.48	2.14	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.02	0.64	0.64	6.27	0.32	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	71.48	5.23	1.74	14.60	1.74	2.40	0.22
small intestine, adult, pool1	10024-101D6	28.43	10.87	6.33	5.85	8.48	10.15	0.36
small intestine, fetal, donor1	10064-101I1	22.36	2.46	3.19	2.95	3.44	1.47	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	48.21	3.08	3.59	3.59	2.56	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	35.67	5.94	3.10	3.36	1.03	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	8.58	2.14	1.34	0.54	0.80	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	37.62	2.75	2.52	2.52	0.23	0.46	0.46
spinal cord, adult, donor10252	10159-103A6	50.86	6.31	2.37	4.73	0.79	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	22.14	4.15	3.46	2.08	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	32.93	3.05	3.05	4.27	1.22	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	31.23	5.05	2.30	2.30	1.38	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.77	8.66	3.88	1.34	2.99	1.19	0.00
spleen, adult, pool1	10025-101D7	24.67	8.15	4.74	3.08	2.97	2.42	0.22
spleen, fetal, pool1	10044-101F8	21.93	6.44	3.73	2.07	2.62	2.78	1.11
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.50	15.53	6.62	2.48	7.97	4.87	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	70.44	9.49	4.56	4.94	4.18	2.09	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.80	5.24	4.19	4.54	1.75	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	79.36	50.82	11.73	19.55	13.68	7.43	7.82
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	105.81	24.65	15.53	13.73	11.82	12.16	4.28
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	21.60	0.85	3.81	4.66	0.00	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	37.23	16.08	4.23	1.69	5.50	0.00	0.85
stomach, fetal, donor1	10062-101H8	53.40	6.41	3.20	3.20	1.07	3.20	0.00
submaxillary gland, adult	10202-103F4	28.48	7.41	5.13	3.42	5.13	2.85	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	61.48	6.65	2.28	4.36	0.83	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	28.45	8.28	3.62	2.07	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	15.54	1.41	2.83	2.12	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.98	10.55	2.75	6.19	2.06	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	30.09	4.66	2.37	2.71	0.17	0.68	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	43.45	3.56	0.71	8.55	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.03	2.20	1.76	6.15	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	13.96	8.03	4.54	1.40	4.54	1.05	1.05
tenocyte, donor2	11765-123I1	10.68	7.63	2.67	0.76	5.72	0.76	0.76
tenocyte, donor3	11768-123I4	8.90	6.67	1.85	0.74	4.08	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.64	3.57	0.68	7.48	0.51	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	39.00	0.77	0.31	5.09	0.00	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	26.35	0.31	0.62	3.25	0.62	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.20	3.81	2.16	5.20	2.67	0.63	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	37.06	2.27	0.76	6.43	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.88	2.51	4.69	2.94	3.27	1.20	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	25.40	1.95	3.26	3.58	1.95	0.33	0.00
testis, adult, pool1	10026-101D8	29.96	5.05	5.91	3.22	1.83	0.75	0.21
testis, adult, pool2	10096-102C6	33.83	0.90	11.73	4.06	3.61	0.00	0.00
thalamus - adult, donor10196	10168-103B6	33.12	5.52	8.83	1.10	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	59.39	6.56	2.50	3.75	1.09	0.78	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	4.62	1.54	3.08	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.66	2.96	1.15	1.15	0.33	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	16.11	5.75	1.73	1.15	0.00	0.58	1.15
throat, adult	10209-103G2	24.22	9.99	4.24	2.25	4.99	3.50	0.50
throat, fetal, donor1	10061-101H7	30.47	4.88	3.05	3.66	2.13	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	40.14	2.38	0.79	5.96	0.79	0.20	0.00
thymus, adult, pool1	10027-101D9	58.95	6.96	7.85	5.57	3.58	1.19	0.10
thymus, fetal, pool1	10043-101F7	84.37	14.55	6.86	10.60	2.18	2.39	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	20.61	4.25	4.12	1.73	3.86	1.86	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	23.33	4.19	5.31	1.54	3.91	1.26	0.00
thyroid, adult, pool1	10028-101E1	33.97	5.60	3.55	4.20	1.77	1.59	1.03
thyroid, fetal, donor1	10060-101H6	32.69	4.75	6.06	2.64	3.43	1.58	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	3.08	6.16	3.08	0.00	6.16
tongue, adult	10203-103F5	20.70	5.81	2.79	2.33	2.09	2.09	0.93
tongue, fetal, donor1	10059-101H5	27.59	7.88	1.97	3.15	1.58	1.18	0.79
tonsil, adult, pool1	10047-101G2	32.96	14.33	7.21	4.31	5.91	5.31	0.90
trachea, adult, pool1	10029-101E2	18.00	6.71	5.07	2.04	2.70	2.29	0.16
trachea, fetal, donor1	10058-101H4	22.31	5.00	5.77	1.92	1.15	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.40	4.25	3.90	1.42	4.96	1.42	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.05	3.95	2.94	2.53	2.43	0.91	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.74	7.68	4.23	0.94	2.98	1.57	0.00
tridermal teratoma cell line:HGRT	10694-109G1	26.64	5.71	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.55	4.66	2.54	2.54	1.02	0.59	0.34
umbilical cord, fetal, donor1	10057-101H3	25.04	12.52	4.17	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	39.93	5.80	3.24	2.90	2.56	1.02	1.54
uterus, fetal, donor1	10055-101H1	30.20	5.12	4.61	4.10	1.54	1.02	1.02
vagina, adult	10204-103F6	21.32	2.58	1.94	1.29	3.88	3.23	3.23
vein, adult	10191-103E2	28.28	5.92	5.26	2.85	3.51	3.07	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.76	4.54	4.54	2.14	2.40	2.40	0.00